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CHAPTER 1:  INTRODUCTION 
 
1.1 Epigenetic Mechanisms 
Epigenetics is defined as heritable patterns of gene expression that occur without 
changes to DNA sequence.  Epigenetic regulation is crucial for the process of cellular 
differentiation and development as evidenced by distinctly different sets of gene 
transcripts found in diverse tissues despite carrying identical genetic information 
(Bartolomei & Tilghman, 1997; Felsenfeld & Groudine, 2003).  Epigenetic control is 
largely facilitated by regulation of transcription through dynamic remodeling of 
chromatin structure. 
The basic unit of chromatin is the histone core, an octomer of four histone 
proteins, H2A, H2B, H3, and H4 and approximately 147 base pairs of DNA wrapped 
around it.  Actively transcribed chromatin is found in a more open configuration called 
euchromatin in contrast to non-transcribed heterochromatin found in a tightly closed 
configuration.  Specific post-translational modifications including acetylation, 
phosphorylation, sumoylation, ubiquitination and methylation of specific amino acids on 
histone proteins have been associated with chromatin status (Felsenfeld & Groudine, 
2003; Grewal & Moazed, 2003; Jaenisch & Bird, 2003).  For example, H3 methylated at 
lysine 4 (H3K4) is associated with euchromatin and H3 methylated at lysine 9 (H3K9) is 
associated with heterochromatin.  Many of the enzyme complexes associated with these 
specific post-translational modifications have been identified, however the specific events 
that lead to the targeting of these enzymes are still largely unknown. 
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Methylation of mammalian DNA provides an additional mechanism for 
epigenetic control.  Cytosine methylation, covalent attachment of a methyl group at the 
C5 position of cytosine, occurs usually in the context of CpG dinucleotides and is largely 
associated with gene repression (Bird, 2002).  Methyl cytosine spontaneously deaminates 
to thymine, whereas unmethylated cytosine converts to uracil.  If left unrepaired, thymine 
would be recognized as a valid base and DNA replication would result in a shift to 
adenosine instead of guanine at that location.  It is believed that as a consequence of 
DNA repair efficiency (lower for thymine vs. uracil) following spontaneous cytosine 
deamination, CpG dinucleotide distribution is found at only ~10% of the expected 
frequency throughout the mammalian genome (Bird, 2002;  Antequera & Bird, 1993; 
Larsen et al., 1992).  However, CpG dinucleotides are found at the expected frequency in 
clusters of non-methylated CpG dinucleotides denoted CpG islands (CGI).  
Unmethylated CpG dinucleotides are enriched in regions near promoters of 60-70% of all 
human genes (Lander, 2001).  CGIs colocalize with the promoters of all human genes and 
approximately 40% of those found expressed in a tissue restrictive manner (Larsen et al., 
1992;  Zhu et al., 2008).  Several transcripts initiate from intragenic CGIs and are 
expressed during specific developmental stages (Macleod et al., 1998;  Kleinjan et al., 
2004). 
The de novo DNA methyltransferases (Dnmt) Dnmt3a and Dnmt3b establish 
cytosine methylation patterns during early development (Okano et al., 1999) and Dnmt1, 
which preferentially acts on the hemi-methylated DNA replication product, is largely 
responsible for maintaining the pattern (Yoder et al., 1997).  Lower eukaryotes do not 
utilize cytosine methylation as a mechanism for epigenetic regulation, however this 
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machinery is critical for mammalian development, as ablation of any of the Dnmt genes 
in mice is lethal (Lei et al., 1996;  Okano et al., 1999).  Alteration of cytosine methylation 
patterns is frequently observed in cancers (Baur et al., 1999;  Guo et al., 2000;  Issa et al., 
1997;  Hennessy et al., 2003) and leads to disease states such as immunodeficiency (Xu 
et al., 1999).  Dynamic cytosine methylation plays an important role in gametogenesis, X 
chromosome inactivation and genomic imprinting and changes in DNA methylation 
along with histone modifications are necessary for in vitro differentiation of embryonic 
stem (ES) cells (Bestor, 2000;  Okano & Li, 2002;  Yokochi & Robertson, 2002).  ES 
cells carry a relatively open chromatin structure and the orderly restriction of lineage 
potential during development is associated with progressive accumulation of 
heterochromatin and restriction of gene expression (Akashi et al., 2003;  Attema et al., 
2007).   
 
1.2 H3K4 Methylation and Enzymatic Complexes 
Lysine methylation occurs in either a mono-, di- or trimethylated form (Santos-
Rosa et al., 2002).  Trimethylation of H3K4 is largely associated with actively or recently 
transcribed genes (Ng et al., 2003a) although H3K4 trimethylation has been identified in 
non-transcribed developmental genes in embryonic stem cells (Bernstein et al., 2006).  
The H3K4 trimethylation mark is primarily found at promoter and transcription start sites 
within the gene (Guenther et al., 2007).  Dimethylation is predominantly identified in the 
middle, and mono-methylation is predominantly identified toward the 3’ end of actively 
transcribed genes (Pokholok et al., 2005), although the function of mono- and di-
methylation remains unknown.  Interestingly, under transcriptional stress induced by 
  4
depletion of nucleoside triphosphates, trimethylation appears at the 3’ end of the coding 
region, suggesting specific signaling factors are involved in regulating H3K4 
methyltransferase activity (Ng et al., 2003a).  
In yeast, a single multi-component enzymatic complex known as Set1/COMPASS 
performs H3K4 methylation.  Set1/COMPASS is comprised of a large scaffold protein, 
called Set1, containing a conserved catalytic C-terminal SET domain (named from the 
Drosophila genes Su(var) 3-9, Enhancer of zeste, and trithorax) (Jenuwein, 1998) as well 
as an N-terminal RNA recognition motif (RRM).  Seven additional proteins belong to the 
complex, most of which are required for efficient H3K4 methylation.  Interestingly, 
deletion of Set1 abolishes all H3K4 methylation in Saccharomyces cerevisiae, yet it is 
not lethal (Boa et al., 2003;  Briggs et al., 2001;  Roguev et al., 2001).  However, Set1 
deletion affects numerous important functions such as growth, transcriptional activation, 
repression and elongation, ribosomal DNA silencing, meiotic differentiation, DNA 
repair, chromosome segregation, and cell wall organization as well as telomere length 
regulation.  For example, deletion of Set1 results in aberrant position dependent gene 
silencing at telomeres, the mating type locus and ribosomal DNA in Saccharomyces 
cerevisiae (Briggs et al., 2001;  Corda et al., 1999;  Krogan et al., 2002;  Nislow et al., 
1997).  Defects in these cellular processes following deletion of Set1 suggests 
Set1/COMPASS is targeted to genes within these functional pathways, although the 
mechanism for targeting remains elusive.   
Set1 associates with the coding regions of highly transcribed RNA polymerase II 
(Pol II) genes, and the presence of Set1 generally correlates with H3K4 trimethylation 
(Ng et al., 2003c).  Set1 associates with Pol II when it’s carboxyl-terminal heptad repeat 
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domain (CTD) is phosphorylated at Serine 5, a mark of transcription initiation (Ng et al., 
2003c), and this association is dependent on the Paf1 complex and the mono-
ubiquitination of lysine 123 on histone H2B by Rad6/Bre1 (Krogan et al., 2003;  Mueller 
& Jaehning, 2002).  The Paf1 complex is required for Rad6/Bre1 activity, but not 
targeting of the ubiquitin protein ligase to promoters (Krogan et al., 2003).  H2B 
ubiquitination is a requirement for di- and trimethylation by Set1, but not mono- 
methylation (Hwang et al., 2003;  Ng et al., 2003b;  Dehé et al., 2005;  Shahbazian et al., 
2005). 
Only one subunit of the Set1/COMPASS complex, Swd2, is essential for survival 
in yeast (Cheng et al., 2004;  Dichtl et al., 2004;  Roguev et al., 2004).  Interestingly, 
Swd2 is reported to be a component of the cleavage and polyadenylation factor (CPF) 
necessary for mRNA processing and transcription termination in addition to the 
Set1/COMPASS complex (Cheng et al., 2004;  Dichtl et al., 2004;  Roguev et al., 2004).  
Recruitment to CPF is dependent on the Ref2 subunit, an RNA-binding protein known to 
stimulate processing at weak poly(A) sites (Cheng et al., 2004).  Swd2 mutations 
generated with error prone PCR mutagenesis resulted in variable effects depending on 
which gene was evaluated in Saccharomyces cerevisiae, suggesting the function of Swd2 
in linking H3K4 methylation and Pol II termination may be gene dependent (Cheng et al., 
2004). 
Other components of the yeast Set1/COMPASS complex include Sgh1 (Cps 15), 
Swd1 (Cps 50), Swd3 (Cps 30), Bre2 (Cps60), Sdc1 (Cps25) and Spp1 (Cps 40) (Roguev 
et al., 2001;  Nagy et al., 2002;  Miller et al., 2001).  Swd1 and Swd3, which remain 
associated with each other in the absence of Set1, are essential for the integrity of the 
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COMPASS complex and stability of Set1 (Morillon et al., 2005;  Roguev et al., 2001; 
Schneider et al., 2005).  Bre2, Sdc1 and Spp1 are required for proper trimethylation 
levels and location within the transcribed genes (Dehé et al., 2006).  Mono- and di-
methylation levels are influenced by Bre2/Sdc1, but not Spp1 (Dehé et al., 2006).  Spp1 
also plays a role in Set1 stability as cells lacking Spp1 show a clear reduction in the level 
of Set1 (Nagy et al., 2002;  Roguev et al., 2001;  Schneider et al., 2005).  These proteins 
are also highly conserved in organisms from yeast to humans (Roguev et al., 2001;  
Roguev et al., 2003).  
In contrast to yeast, humans have multiple H3K4 methyltransferase complexes 
including Setd1A, Setd1B, Mll1-4, Smyd 3 and Set7/9.  The family of H3K4 
methyltransferases is widely expressed and appears to have non-redundant functions, as 
deletion or disruption of a single member can result in either death or disease.  For 
example, Mll1 plays a role in development and hematopoiesis as the translocation of the 
Mll1 gene is observed in multiple types of leukemia (Tenney & Shilatifard, 2005).  
Genetic disruption of Mll1 or Mll2 results in embryonic lethality (Glaser et al., 2006;  
Ayton et al., 2001).  Although Mll1 catalyzes H3K4 methylation of two specific genes, 
HoxA9 and HoxC8 (Ansari et al., 2008), and Mll2 has been shown to be required for 
male and female gamete development in mice (Andreu-Vieyra et al., 2010), the specific 
mechanism and targeting of each H3K4 methyltransferase remains to be determined. 
 
1.3 Setd1A and Setd1B  
Setd1A and Setd1B are the most closely related to the yeast Set1, including 
association with all six non catalytic components comprised of Cfp1 (Spp1 analog), 
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Rbbp5 (Swd1 analog), Ash2 (Bre2 Analog), Wdr5 (Swd3 analog) and Wdr82 (Swd2 
analog).  In contrast, Mll1 and Mll2 associate with Cfp1 (Ansari et al., 2008)  but not 
Wdr82 (Lee et al., 2010), and Mll3 and Mll4 associate with Wdr82 but not Cfp1 (Lee et 
al., 2010).  The two Setd1 methyltransferases exhibit both overlapping and non-redundant 
properties.  Human Setd1A and Setd1B are 85% identical throughout the catalytic SET 
and post-SET domains and 61% identical throughout the N-terminal region that includes 
a RRM domain (Lee et al., 2007).  The central region contains only 46% identity (Lee et 
al., 2007).  Inducible expression of the C-terminus of either Set1dA or Set1dB decreases 
steady-state levels of both endogenous Set1dA and Set1dB proteins, but does not alter the 
expression of the associated components of the Set1 complexes (Lee et al., 2007). 
However, nuclear localization of these two methyltransferases are largely non-
overlapping and mostly confined to euchromatin speckles as seen in confocal 
microscopy,  suggesting distinct gene targets (Lee et al., 2007).  In addition, a host cell 
factor 1 (HCF-1) binding motif unique to the Setd1A central region interacts with HCF-1 
in vivo (Lee et al., 2007;  Tyagi et al., 2007), but is not found in Setd1B.  Interestingly, 
HCF-1 mediated recruitment of Mll1 to E2F responsive promoters by E2F1 promote cell 
cycle progression (Takeda et al., 2006;  Tyagi et al., 2007).  The significance of HCF-1 in 
the cell cycle and its association with Setd1A but not Setd1B is consistent with separate 
and distinct roles for the two Setd1 proteins. 
As in yeast, human Setd1 H3K4 methyltransferases localize with Pol II (Ng et al., 
2003a;  Lee & Skalnik, 2008), and are highly associated with the 5’ end of actively 
transcribed genes.  However, in contrast to the yeast requirement for association with the 
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Paf1 complex for Set1 interaction with Pol II,  the human Setd1A and Setd1B complexes 
associate with Pol II by interaction with Wdr82 (Lee & Skalnik, 2008). 
 
1.4 Wdr82  
Set1/COMPASS subunits of budding and fission yeast have been extensively 
characterized, however much less is known about the mammalian homologue.  Only 4 
publications provide specific information on Wdr82.  Wdr82 is one of three COMPASS 
subunits made up of multiple WD-40 motifs, a motif with circular propeller-like 
structures which can interact sequentially or simultaneously with several different 
proteins.  Wdr82 associates with the RRM domain of Setd1A and directly recognizes 
phosphorylated serine 5 in the CTD of the Pol II large subunit, but does not associate 
under conditions of unphosphorylated serine 5, or phosphorylation at serine 2 found 
during transcription elongation (Lee & Skalnik, 2008).  Depletion of Wdr82 by small 
interfering RNA leads to decreased Setd1A expression and occupancy at transcription 
start sites coupled with reduced H3K4 trimethylation (Lee & Skalnik, 2008).  Recently, 
Wdr82 has been identified in association with other protein complexes including a 
protein phosphatase 1 (PP1) containing complex, a chaperone containing Tcp1 complex 
and other uncharacterized proteins (Lee et al., 2010) indicating a role in multiple 
functions. 
 
1.5 Cfp1  
Similar to Wdr82, a decrease in Cfp1 protein levels leads to reduced Setd1A 
protein levels, however, global levels of H3K4 trimethylation increases (Tate et al., 
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2010).  In yeast, the homolog Spp1 is not required for survival, however deletion of Cfp1 
results in embryonic lethality in mice as homozygously disrupted Cfp1 allele mice could 
not be recovered from heterozygous mice matings. (Carlone & Skalnik, 2001).  
Blastocysts lacking Cfp1 appear normal and appear to implant but fail to gastrulate.  ES 
cell lines lacking Cfp1 are viable, but present an altered phenotype with an increased rate 
of apoptosis and an inability to differentiate (Carlone et al., 2005;  Tate et al., 2009b).  ES 
cells lacking Cfp1 also exhibit a dramatic decline in global cytosine methylation and 
altered histone modifications associated with heterochromatin (Carlone et al., 2005;  Lee 
& Skalnik, 2005;  Tate et al., 2010) as well as a global reduction in protein synthesis 
despite evidence of increased transcripts for some genes (Butler et al., 2008;  Butler et al., 
2009).    
Cfp1 exhibits a unique binding specificity to DNA sequences containing 
unmethylated CpG motifs (Voo et al., 2000) and a search for proteins common to all 
CGI’s showed a high level of enrichment of Cfp1 (Thomson et al., 2010).  A reduction of 
H3K4 trimethylation in CGIs was reported in Cfp1 depleted NIH 3T3 cells suggesting 
genes associated with CGIs are likely targets for Cfp1 interacting methyltransferases.  In 
addition to binding unmethylated CpG motifs, Cfp1 interacts directly with Dnmt1, the 
maintenance DNA methyltransferase, independently of association with the Setd1 H3K4 
methyltransferase complexes (Butler et al., 2008), suggesting Cfp1 may enable crosstalk 
between the histone and DNA methylation epigenetic marks.  Remarkably, transfection 
studies in ES cells reveal that either the carboxyl half which has a SET binding motif, or 
the amino terminal half containing the DNA binding motif of Cfp1, is sufficient to rescue 
defects of Cfp1 depleted ES cells, provided the binding motifs within are not altered 
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(Tate et al., 2010).  Three fragments of the Cfp1 protein, the carboxyl half and two within 
the amino half, are sufficient to interact with Dnmt1 (Butler et al., 2008).  Taken together, 
these data suggest Cfp1 plays a critical role in regulating chromatin configuration and 
consequent transcriptional expression through epigenetic mechanisms and may play a 
role in developmental changes in DNA methylation. 
 The following studies further investigate the impact of altering protein levels and 
protein configuration for Setd1 complexes and the critical components, Wdr82 and Cfp1.  
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CHAPTER 2:  MATERIALS AND METHODS 
 
2.1 Cell culture conditions and staining procedures 
2.1.1 ES cell culture 
Undifferentiated ES cells were grown on tissue culture plates coated with 0.1% 
gelatin in media containing high glucose Dulbecco’s modified Eagle Medium (DMEM) 
(Gibco BRL), 20% fetal bovine serum (FBS)(Gibco), 100 units Pennicillin/Streptomycin 
(Pen/Strep) (Invitrogen), 2 mM L-Glutamine (Invitrogen), 1% non-essential amino acids 
(Invitrogen), 0.2% conditioned medium from leukemia inhibitory factor (LIF) generating 
chinese hamster ovary cells and 100 mM BME solution made with 100 nM β-
mercaptoethanol (BME), 0.025% 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) pH 7.5, 1% Hank’s balanced salt solution (Invitrogen). 
 
2.1.2 Differentiation of ES cells 
To induce differentiation, asynchronous exponentially growing cells were 
trypsinized and transferred to conical tubes for centrifugation and removal of media 
containing LIF.  Cells were washed two times and re-suspended in growth media without 
LIF, and plated at 1 x 107 cells per plate without gelatin.  ES cells were monitored daily 
for morphological changes on an inverted light microscope (10x) and media was changed 
on day 3 being careful not to disrupt embroid-like bodies if present. 
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2.1.3 β-galactosidase staining of ES cells 
Wild type (WT) ES cells and an ES cell line which has a β-galactosidase (LacZ)  
gene inserted between exons 3 and 4 of the Wdr82 gene, obtained from the Mutant 
Mouse Regional Resource Center (AZ0280) (designated hereafter as Wdr82 Het), were 
grown in ES cell media as described above.  Media was removed from asynchronous 
exponentially growing cells, followed by a wash with PBS and cells were fixed with X-
gal fix buffer (0.1 M phosphate buffer pH 7.3 supplemented with 5 mM ethylene glycol 
tetraacetic acid [EGTA] pH 7.3, 2 mM MgCl2 and 0.2% gluteraldehyde) for 15 minutes 
at room temperature (RT).  The cells were washed twice with X-gal wash buffer (0.1 M 
phosphate buffer pH 7.3 supplemented with 2 mM MgCl2) followed by addition of X-gal 
staining buffer [0.1 M phosphate buffer pH 7.3 supplemented with 2 mM MgCl2, 5 mM 
potassium ferrocyanide (K4Fe(CN)6-3H2O) and 5 mM potassium ferricyanide 
(K5Fe(CN)6) with 1 mg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal)] with 
just enough liquid to cover the cells and placed inside a humidified darkened chamber at 
37˚C overnight.  The following day, X-gal staining buffer was removed, cells were 
washed with X-gal wash buffer and observed for blue color indicating β-galactosidase 
activity with the inverted light microscope under 10x magnification. 
 
2.1.4 Human embryonic kidney (HEK) 293 T-rex growth media and expression induction  
Stable doxycycline inducible HEK 293T-rex cell lines transfected with various 
Setd1B cDNA fragments, full length Setd1A, full length Setd1B or vector were cultured 
in DMEM tissue culture media containing 10% fetal calf serum (FCS) (Gibco BRL), 50 
units Pen/Strep (Invitrogen), 2 mM L-Glutamine (Invitrogen), 20 µl of 25 mg/ml 
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blasticidin, and 500 µl hygromycin.  To induce expression of cDNAs, 1 mg/ml 
doxycycline was added to cell media.  The cell lines were supplied by Dr. Jeon-Heong 
Lee. 
 
2.1.5 HEK 293 T-rex cell growth counting 
Stably transfected HEK 293 T-rex cell lines were plated in duplicate at 5 x 104 
cells per well and induced to express the vector DNA by of doxycycline to the growth 
media.  At 24 hour intervals for four days, cells were collected and counted in triplicate 
by hemocytometer under the light microscope.  To maximize complete collection of all 
cells for counting, all fluid and/or cells were transferred into a single conical tube for 
each step in the cell collection process, followed by centrifugation to concentrate and re-
suspension for counting.  Briefly, growth media was removed, cells washed once with 
PBS followed by addition of trypsin and two additional well washes with PBS.  Cells 
were spun at 4˚C to form a pellet and re-suspended in 1 ml of media lacking doxycycline.  
Trypan Blue was added to cells for visualization and counting by hemocytometer.  Only 
viable cells were counted. 
 
2.1.6 Cell cycle analysis by propidium iodide 
Asynchronous exponentially growing induced HEK 293 T-rex cells cultured in 
media containing doxycline were trypsinized, counted and adjusted to 5 x 105 cells/tube 
followed by two washes in cold PBS.  Cells were re-suspended and fixed in cold 70% 
ethanol and stored at -20˚C overnight or until analysis.  Cells were washed twice in cold 
PBS and re-suspended in fresh propidium iodide (PI) buffer (0.5 mg/ml propidium 
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iodide, 0.1% Triton-X-100, 1 mM ethylenediaminetetraacetic acid [EDTA], 4 mg/ml 
RNAase A in PBS pH 7.4, 100 µg/ml) for DNA staining.  Cells were maintained on ice 
protected from light until analysis on the fluorescent antibody cell sorter (FACS) using 
standard PI programming for cell cycle analysis on FACScan flow cytometer (Becton 
Dickinson).  Multiple biological samples were evaluated, and duplicate technical samples 
were stained and analyzed within each biological sample. 
 
2.2 Protein analysis by western blot 
2.2.1 Cellular extracts 
WT and Wdr82 Het ES cells were harvested for protein analysis.  For each 
sample, ES cells from two to three 15 cm culture plates were removed and placed into a 
15 ml conical tube, followed by centrifugation at 1200 rpm for 2 minutes at 4˚C.  
Supernatant was removed and cells were re-suspended in 4˚C hypotonic buffer (10 mM 
HEPES, 1.5 mM MgCl2, 10 mM KCl supplemented with 1 µg/ml each leupeptin, 
aprotinin, pepstatin, 1 mM phenylmethysulfonyl fluoride (PMSF) and 1 mM 
Dithiothreitol (DTT) for protease inhibition and placed on ice for 10 minutes, followed 
by homogenation with 10 strokes of Dounce homogenizer and centrifugation at 16,000 x 
g for 10 minutes at 4˚C.  Supernatant containing cytosolic components was transferred to 
a separate tube and cell pellets were re-suspended in cyto-skeletal buffer (10 mM 1,4-
piperazinediethanesulfonic acid [PIPES] pH 7.0 300 mM NaCl, 300 mM sucrose, 3 mM 
MgCl2, 1 mM EGTA, and 0.5% Triton X-100) supplemented with 1µg/ml each leupeptin, 
aprotinin, pepstatin and 1 mM PMSF and 1 mM DTT and incubated on ice for 10 min, 
followed by homogenization with 10 strokes in Dounce glass homogenizer.  The 
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solubilized nuclear fraction was separated by centrifugation at 16,000 x g for 10 minutes 
at 4˚C. 
 
2.2.2 SDS Page electrophoresis and western blot 
Nuclear extracts were mixed with 4x concentrated Laemmli sample buffer (20% 
glycerol, 2% sodium dodecyl sulphate [SDS], 5% BME, 0.1% bromophenol blue and 
62.5 mM tris[hydroxymethyl]aminomethane [Tris], pH 6.8) and heated for 5 minutes at 
95˚C then placed on ice to cool.  Protein samples (10-15 µl) were subjected to 
electrophoresis on 8% gel and transferred to nitrocellulose membranes (Amersham, GE 
Healthcare).  The membranes were blocked with 5% milk in Tris buffered saline with 
Tween (TBST) for one hour and washed three times with TBST before being probed with 
primary antiserum rabbit polyclonal anti WDR82 (WD518A), 1:1000 or mouse 
monoclonal β-actin 1:1000 (Sigma-Aldrich) for 1 hour at RT or overnight at 4˚C.  
Membranes were washed three times with TBST and incubated with horseradish 
peroxidase labeled secondary antibody 1:1000 for 1 hour at RT.  Membranes were 
washed three times with TBST and signal was detected with ECL kit (Amersham, GE 
Healthcare).   
 
2.3. Embryo collection and analysis 
2.3.1 Timed pregnancy 
 C57BL/6J mice heterozygous for disrupted Wdr82 gene (Wdr82(+/-)) mice were 
mated.  Two Wdr82(+/-) females were caged overnight with one Wdr82(+/-) male.  The 
females were checked for vaginal plugs the following morning and the appearance of 
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vaginal plug was designated as day 0.5 of gestation.  Pregnant females were sacrificed at 
day 9.5 to 11.5 by CO2 inhalation and embryos were harvested, washed in PBS pH 7.3 
and observed for phenotypic defects.  The care and use of animals in these studies were 
approved by the Indiana University School of Medicine Institutional Animal Care and 
Use Committee. 
 
2.3.2 Embryo Digestion 
Embryos obtained from Wdr82(+/-) matings were digested in cell lysis buffer (10 mM 
Tris, 100 mM EDTA, 0.5% SDS pH 8.0) plus 20 mg/ml proteinase K (Roche) and 
incubated at 55˚C for 4-24 hours depending on the size of embryo.  Solution was put on 
ice to cool and incubated with 5 µl RNAse A (10 mg/ml) for 15 minutes at 37˚C and 
returned to ice to cool.  To precipitate protein, 7.5 M ammonium acetate (200 µl) was 
added, samples were vortexed for 20-30 seconds and put on ice for 5 to 30 minutes.  
Tubes were spun in a micro-centrifuge at maximum speed at 4˚C for 15 minutes and 
supernatant was transferred to a fresh tube for DNA precipitation. 
 
2.3.3 DNA precipitation 
To precipitate DNA, 70% volume/volume isopropanol was added to microfuge 
tube containing DNA supernatant and inverted to mix several times followed by a spin in 
micro-centrifuge at maximum speed for 1 minute at RT to form a DNA pellet.  
Supernatant was poured off and the pellet was washed with 70% ethanol, followed by a 
wash with ice cold 100% ethanol and allowed to air dry.  DNA pellets were re-suspended 
in 50 µl sterile distilled water. 
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2.3.4 Genotyping by Polymerase Chain Reaction (PCR) 
Multiplex PCR was performed with 1 µl re-suspended DNA in a 50 µl reaction 
mixture containing 0.2 mM of each deoxynucleotide triphosphate (dNTP), 50 pmol each 
of forward primer P8a and backward primers P7 and P2a, 1 unit of Taq DNA polymerase 
(Roche) in 10x buffer supplied by the manufacturer (10x PCR buffer with MgCl2). 
Cycling conditions for PCR included heat denaturation at 94˚C for 4 minutes, followed 
by 25 cycles of 94˚C for 1 minute, 62˚C for 1 minute, and 72˚C for 1 minute, and a final 
elongation step at 72˚ C for 10 minutes.  Previously characterized mouse tail and ES cell 
DNA samples were used as controls.  PCR products (25 µl) were run on a 1.5% agarose 
gel with ethidium bromide.  The size was determined by a 100 bp DNA standard ladder. 
Primer sequences used:    
P2a  5’- CAGGTTTGCCCTGTAGATGCATGAG - 3’ 
P8a  5’- ACTGAGCCAGCCTTTCATGGCAGC - 3’ 
P7    5’- TACCCCAGACCTTGGGACCACC - 3’ 
 
2.4 ES cell line microarray analysis 
2.4.1 Sample preparation and hybridation 
Murine ES cell lines, including one wild type (WT), two CFP1 disrupted  (N1 and 
N2), and one N1 ES cell line transfected with human CFP1 cDNA (Rescue) were grown 
in media containing LIF.  Asynchronous exponentially growing cells were processed for 
total RNA by Courtney Tate.  Four biological samples from each cell line were handled 
in parallel to reduce non-random error and supplied to the Indiana University Core Center 
for Genomics facility for analysis.  Briefly, total RNA samples were labeled using the 
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Affymetrix standard One-Cycle protocol and hybridized to Affymetrix Mouse Genome 
430 2.0 GeneChips® according to standard Affymetrix protocols.  GeneChips were 
scanned with an Affymetrix Model 3000 scanner controlled by GCOS software 
(Affymetrix).  Microarray Suite version 5 (MAS5) signals and detection call were 
generated and scaled using a target of 1000.   
 
2.4.2 Data analysis 
The Affymetrix MAS5 algorithm was used to analyze the hybridization intensity 
data from each array.  The MAS5 data were imported into Partek Genomics Suite 
(Partek, Inc., St. Louis, MO) software and was log transformed (base 2) followed by 
evaluation of overall characteristics for quality assessment with principal components 
analysis (PCA) and hierarchical clustering.  Gene annotations were supplied by 
Affymetrix (www.Affymetrix.com) from the most recent update (August 10, 2010).  
Probe sets were then removed unless a determination of “present” was made in at 
least 50% of the replicates within a minimum of one of the experimental cell line groups 
(McClintick & Edenberg, 2006).   
To view initial global patterns of gene expression changes and rescue, a one-way 
analysis of variation (ANOVA) was performed using all four cell lines.  The top 100 
genes were selected for hierarchical clustering. 
A two-way ANOVA was performed by genotype (average of WT and Rescue 
designated as WT genotype and average of N1 and N2 designated as NULL phenotype) 
and samples (ES cell line within genotype) plus relevant contrasts.  Euclidian distance, a 
measure employed to identify differences, was used to cluster genotype samples, and 
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Pearson’s Dissimilarity Coefficient, a measure employed to identify similarities, was 
used to cluster the gene probes.     
Contrasts were made for N1 vs. WT, N2 vs. WT, Nl vs. Rescue, Rescue vs. WT, 
and N1 vs. N2.  Statistical determination for p-values, false discovery rate (FDR) 
designated as q-value and fold changes for each of these contrasts were calculated.  FDRs 
were calculated using the method from Storey and Tibshirani (Storey & Tibshirani, 
2003).  The fold change calculation was based on the untransformed signal.  Statistical 
analysis was performed by The Center for Medical Genomics at Indiana University- 
Purdue University Indianapolis (IUPUI).   
 Probe lists for functional analysis were generated using two-way ANOVA 
contrasts and imported into the database for annotation, visualization and integrated 
discovery (DAVID) bioinformatics resources (http://david.abcc.ncifcrf.gov/).  First, data 
was filtered to remove probes not called present in at least 50% of any cell line tested.  
Due to the high number of genes identified as statistically different, a filter was applied to 
reduce the number of genes submitted to DAVID and increase the confidence in 
functional annotation analysis.  Probes statistically significant in N1 vs. WT, N2 vs. WT 
and N1 vs. Rescue contrasts at p<.0001 and consistent fold change +/- 1.5 were identified 
and separated into up-regulated and down-regulated gene lists and subsequently 
submitted to DAVID for analysis (October, 2010).  Multiple probes representing the 
same gene were removed to eliminate over-representation.  
To evaluate genes that did not rescue, a filter of p<.05 was initially evaluated in 
all N1 vs. WT, N2 vs. WT and N1 vs. Rescue contrasts where N1 and N2 vs. WT were 
up-regulated but N1 vs. Rescue was down-regulated and vice versa.  After submission to 
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DAVID for analysis, the lists were further filtered with fold change cutoff +/- 1.5 and 
resubmitted.  Gene Ontology Biological Process was evaluated by DAVID and 
Affymetrix annotation. 
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CHAPTER 3:  RESULTS 
 
3.1 Wdr82 is required for early embryonic development 
Previously, cross-breeding of heterozygous Wdr82 mice in our lab resulted in no 
viable mice that were homozygous for the disrupted Wdr82 allele, indicating that Wdr82 
is essential for murine development.  To determine the time in development that Wdr82 
is required, we collected embryos from heterozygous Wdr82 mice matings at day 9.5 to 
11.5 days post coitum (dpc), the earliest time point that embryo and placental material 
can be clearly separated.  The embryos were observed for phenotypic defects and none 
were observed (data not shown).  To identify the genotype of embryos, multiplex PCR 
was performed using one common forward primer and two backward primers, with one 
being unique to the wild type Wdr82 gene located downstream from the disrupted gene 
location resulting in a higher base pair PCR product, and the second located within the β -
galactosidase disruption cassette, resulting in a smaller product (Figure 1). 
After analysis of 74 embryos, no homozygous disrupted Wdr82 genotypes were 
identified (Table 1).  Interestingly, an overabundance of heterozygous genotype was 
observed and this finding is consistent with the ratio of WT and Wdr82 hets observed in 
full term pups (data not shown).  To look earlier in development, uteri from Wdr82 het 
cross-bred females were collected at day 6.0 to 7.5 dpc.  At this time point, embryos 
cannot be easily separated from the uterine deciduum, therefore uteri were sectioned and 
stained for histological analysis.  Over thirty-five uteri from multiple matings were 
analyzed and no phenotypical differences were observed (data not shown).  These results 
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suggest Wdr82 is required in development prior to day 9.5 of gestation and lack of 
Wdr82 may result in a pre-implantation defect. 
 
3.2 The LacZ gene trap is functional 
LacZ gene trap insertions in ES cells should express detectable levels of the β-
galactosidase reporter in cells with maintenance and/or differentiation culture conditions.  
However, the fusion transcript may not encode a functional β-galactosidase fusion 
product.  For example, insertions that capture the N-terminal signal sequence of a 
secreted or membrane protein are inactive as reported by Skarnes et al. (Skarnes et al., 
1995).  This is likely due to the inability of the enzyme to form a tetramer which is 
required for activity.  Wdr82 is found in the cytoplasm as well as the nucleus and must 
pass through the nuclear membrane.  In order to determine if the β-galactosidase-Wdr82 
fusion product was functional, the Wdr82 het ES cell line used to generate the 
heterozygous Wdr82 mouse was examined.  WT and Wdr82 het ES cells were stained 
with X-gal and observed for blue color indicating β-galactosidase activity.  The 
characteristic blue color was observed in Wdr82 het cells, and not WT, however not 
every cell in the Wdr82 het dish turned blue.  X-gal staining was clearly absent in wild 
type ES cells, indicating the inserted β-galactosidase gene trap is functional (Figure 2).  
  
 3.3 Wdr82 het ES cells have reduced Wdr82 protein levels and exhibit early 
induction of differentiation 
To further characterize the Wdr82 het ES cell line, Wdr82 protein levels were 
analyzed by western blot.  Nuclear lysates demonstrated a reduced amount of Wdr82 
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protein compared to WT ES cells (Figure 3).  Consistently, when utilizing visual 
appearance as a standard for cell quantity, the Wdr82 het cell line exhibited higher levels 
of actin by western blot, a finding that may indicate a slightly higher rate of cell division 
which should be evaluated further (data not shown). 
 ES cell differentiation was assessed by washing and re-plating both WT and Wdr82 
het ES cells in media without LIF to induce differentiation.  Typically, when induced to 
undergo differentiation, murine ES cells form embroid-like bodies appearing as free 
floating spherical clusters.  These spherical clusters eventually attach to the non-gelatin 
coated culture plate and begin to generate outgrowth by approximately day 3.  The 
Wdr82 het ES cells formed embroid-like bodies similar to WT, however attachment and 
outgrowth occurred early in day 2 (Figure 4).  Taken together with altered Wdr82 levels, 
this suggests a difference in differentiation dynamics may result from altered Wdr82 
levels. 
 
3.4 Setd1A and Setd1B play a role in cell division 
Since Setd1A and Setd1B display largely non-overlapping nuclear localization, we 
speculated that they interact with non-redundant functional gene targets.  It was 
speculated that since HCF-1 interaction with Setd1A is involved in cell cycle progression 
and unique to Setd1A, an evaluation of growth and cell cycle differences could elucidate 
the structural region responsible for functional differences between the Setd1 proteins.  
Exogenous expression of progressively larger N-terminal truncations of Setd1B cDNA 
should help identify the structural component unique to Setd1B.  N-terminal truncations 
in this study are named by the nucleic acid in which the N-terminal truncation fragment 
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initiates, including B-676 which does not contain the RRM motif, and B-2482, B4366, B-
4858, B-4981 or B-5266.  All truncations contain the carboxyl terminal SET and post-
SET domains.  All cell lines expressing either truncated or full length Setd1 proteins 
demonstrated significant differences in cell numbers compared to vector at day 4 
(p<0.0001) indicating both Setd1A and Setd1B play a role in cell division (Figure 5).  
Compared to Setd1A, full length Setd1B and B-676 were significantly different 
(p<0.005) but B-2482 through B-4981 were not, suggesting the region of functional 
difference may be in the area coded between nucleotides 676 through 2482 (Figure 6).  
Interestingly, B-5266, containing only SET and post-SET domains was significantly 
different than both Setd1A and Setd1B in addition to vector, suggesting the C-terminal 
SET domain is sufficient to interact with binding partners influencing cellular division.   
The same clones were analyzed for cell cycle changes by PI analysis.  PI binds DNA 
and the level of PI signal identified by flow cytometry correlates with DNA status.  The 
signal is normalized to identify a single set of chromosomes (G1 phase), completion of 
replication with two sets of chromosomes (G2 phase) and intermediate signals identifying 
cells in the process of replication (S phase).  PI cell cycle analysis revealed a significantly 
higher percentage of cells in G1 phase and fewer cells in S phase for cell lines expressing 
Set1dA, Setd1B, B-2482, B-4855 and B-4981 compared to vector (p<0.01), but no 
statistical difference was identified between Setd1A and Setd1B (Figure 7).  This data 
suggests Setd1A and Setd1B both play a significant role in the cell cycle, however 
functional differences cannot be attributed to cell cycle progression alone.  
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3.5 Cfp1 is critical to regulation of gene expression 
Previously, we identified altered H3K4 trimethylation in ES cells lacking Cfp1 by 
confocal microscopy.  The subnuclear distribution of H3K4 trimethyl specific fluorescent 
antibody colocalized with bright areas of the nucleus when stained with diamidino-2-
phenylindole (DAPI), apparently spreading to regions of heterochromatin (Lee et al., 
2007).  Cfp1 null ES cells have increased levels of Dnmt1 transcripts, but lower levels of 
Dnmt1 protein, and lower levels of protein in general (Butler et al., 2009).  Upon 
induction of differentiation, Cfp1 deficient ES cells failed to differentiate and down-
regulate the pluripotent stem cell marker Oct4 (Tate et al., 2009b).  Altogether, the data 
suggests aberrant gene regulation and expression in absence of Cfp1.  In order to better 
understand which genes are affected by the absence of Cfp1, microarray analysis was 
performed using two independent Cfp1 null ES cell lines generated from the same 
blastocyst harvest designated as N1 and N2.  The null ES cells were compared to WT 
cells and an N1 cell line transfected with human Cfp1 cDNA (Rescue) which rescued 
phenotypic defects observed in CFP1 null cells and expresses approximate WT levels of 
Cfp1.   
 Initial analysis of the microarray data showed tight clustering of the four biological 
replicates within each cell line by both Principal Component Analysis (PCA) and 
hierarchical clustering indicating reliable identity within the cell lines (Figure 8).  The 
WT and Rescue clones clustered tightly together as a group and separated distinctly from 
N1 and N2 most obviously by the PCA component 1 (x-axis) with 18.6% variance 
indicating commonality of WT and Rescue compared to Nulls as a group.  However, N1 
and N2 displayed somewhat divergent characteristics from each other in the PCA 
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analysis observed in y-axis PCA component 2 with 12.9% variance.  Hierarchical 
clustering grouped the two nulls together with only a slightly larger distance between 
them compared to the distance between WT and Rescue validating distinct groupings 
between cell lines with and without Cfp1.  
 A one-way analysis of variation (ANOVA) was performed using the top 100 
probes by p-value (Figure 9) to evaluate expression changes over all four cell lines.  A 
comparison of N1, WT and Rescue showed that a majority of mis-regulated genes were 
rescued, however many of the genes were not.  Of those not rescued, there were a larger 
number of up-regulated genes.  Notably, many of these were also not up-regulated in the 
N2 cell line.  Identification of both similarities and differences between the two Nulls 
suggests some but not all mis-regulated genes are directly related to the absence of Cfp1. 
 To better identify consistency in difference and similarities between WT and Cfp1 
null, a two-way ANOVA was performed.  The average of WT and Rescue was 
designated as “WT genotype” and the average of N1 and N2 was designated as “Null 
genotype”.  The two-way ANOVA compares the samples using both genotype and 
individual cell line.  Hierarchical clustering of the top 100 by p-value using two-way 
ANOVA identified more genes consistently up and down regulated across the two 
“genotypes” compared to one-way ANOVA clustering (Figure 10), demonstrating 
increased utility for identification of Cfp1 affected genes.  FDR (q-value), p-value and 
fold changes were calculated for ES cell lines using both genotype and individual cell 
line calculations to make contrasts between the cell types (data not shown).  Two-way 
ANOVA analysis reveals a large set of statistical differences in contrasts at p< .05, with 
12560 in N1 vs. WT (48%), 11582 in N1 vs. Rescue (44%), 9303 in Rescue vs. WT 
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(39%), 10260 in N2 vs. N1 (39%) and 12044 in N2 vs. WT (46%) (Table 2).  Even at p< 
.0001, the number of differences identified in the contrasts remained high with 4471 in 
N1 vs. WT (17%), 3537 in N1 vs. Rescue (14%), 1927 in Rescue vs. WT (7%), 2741 in 
N2 vs. N1 (11%) and 3777 in N2 vs. WT  (14%) indicating loss of Cfp1 dramatically 
alters gene expression.   
Genes consistently up-regulated or down-regulated in both N1 and N2 which are 
rescued by re-introduction of Cfp1 should indicate a direct correlation to Cfp1.  Two-way 
ANOVA contrasts were evaluated for consistency in directional mis-regulation using N1 
vs. WT, N2 vs. WT followed by N1 vs. Rescue contrasts.  Again, large numbers of 
probes were identified with approximately 29% consistently up or down-regulated in N1 
and N2 (p<.05) and 18% rescued (Table 3).  Consistent with top 100 by p-value in one-
way ANOVA, more up-regulated genes did not rescue compared to down-regulated 
genes.  However less than 1% of the total genes consistently mis-regulated were not 
rescued when using fold change of +/-1.5 as a filter.  The inability to rescue genes may 
indicate changes in DNA methylation or other epigenetic marks that prevent Cfp1 
association with previous targets.  Altogether, this data suggests Cfp1 is a critical 
regulator of both activation and repression of gene expression.   
 
3.6 Multiple cellular processes are impacted by loss of Cfp1 
In order to better understand the biological role of genes affected by the absence 
of Cfp1, the large probe lists were minimized by using highly significant p-value 
(p<.0001) and consistent fold changes in N1, N2 and Rescue vs. WT of +/- 1.5 in two-
way ANOVA contrasts.  Using this filter, 686 probes representing 569 distinct genes 
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were identified, with 60% (343) up-regulated and 40% down-regulated (226) (Tables 4 
and 5, respectively).  The up and down-regulated gene lists were submitted to the 
Database for Annotation, Visualization, Identification and Discovery (DAVID) 
(http://david.abcc.ncifcrf.gov/), a web-based functional annotation analysis tool which 
accesses multiple databases in a single query.  The Gene Ontology Consortium (GO) 
database enables up-to-date controlled vocabularies to describe the role of genes and gene 
products with three categories including molecular function (GO_MF), biological process 
(GO_BP) and cellular component (GO_CC).  Terms within each of these categories are 
structured to allow a broad range of inquiry, from generic classification to detailed terms 
within the classifications.  Gene lists submitted are evaluated for enrichment within 
categories.   
GO_BP analysis associated over 50% of up and down regulated genes with the 
general term cellular process.  Overall, 138 different GO_BP terms were associated with 
the down-regulated genes.  The second highest category associated with  down-regulated 
genes was primary metabolic process making up 37% (87) of the list, followed by 21% 
(49) associated with nucleobase, nucleoside, nucleotide and nucleic acid metabolic 
process and 18% (42) associated with regulation of process (Table 6).  Up-regulated 
genes were associated with 171 GO_BP terms overall.  The second highest category 
comprised 35% (120) of up-regulated genes and associated with biological regulation, 
followed by 14% (49) associated with multicellular organismal development, and 14% 
(48) genes associated with gene expression (Table 7).  
The Protein Analyis Through Evolutionary Relationships (PANTHER) 
classification system classifies genes by their function.  PANTHER molecular function 
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analysis enables a more meaningful analysis of molecular function by eliminating top tier 
GO terms for molecular function.  For example, “receptor” or “transcription factor” is 
more meaningful than “protein binding” or “transcription factor binding”.  Sixteen 
PANTHER molecular functions were associated with up-regulated genes and nine 
associated with down-regulated genes.  Nucleic acid binding topped both lists with 20% 
(47) of down-regulated and 11% (38) of up regulated genes (Table 8).  The second 
highest molecular function identified in each list differed, with 17% (39) down-regulated 
genes associated with transcription factor in contrast to 4% (14) up-regulated genes 
associated with hydrolase.   
The Kyoto Encyclopedia of Genes and Genomes (Kegg) Pathway is a collection 
of manually drawn pathway maps based on the known molecular interactions for 
metabolism, cellular process, human diseases, organismal systems and genetic and 
environmental information processing (http://www. genome.ad.jp/kegg/) (Kanehisa & 
Goto, 2000).  Both up and down-regulated genes were enriched in the 
glycolysis/gluconeogenesis pathway (Table 9).  Down regulated genes were enriched in 
aminoacyl-tRNA biosynthesis, spliceosome, TGF-beta signaling, ribosome, and 
Melanoma pathways.  Up-regulated genes were enriched in Alzheimer’s disease, ether 
lipid metabolism, complement and coagulation cascades, glycerolipid metabolism, 
glycerophospholipid metabolism and tyrosine metabolism.  Taken together, these data 
suggest Cfp1 plays a critical role in regulation of basic cellular processes and signaling in 
addition to development and gene expression. 
In order to identify the biological role of genes which did not rescue, a gene list 
was generated with less stringent parameters due to the smaller data set.  Utilizing 
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consistency in up or down-regulation with disregard to fold change levels and p<.05, only 
138 down regulated and 178 up-regulated genes were not rescued.   
GO_BP associations with non-rescued up-regulated genes were regulation of 
apoptosis (13), RNA processing (12) and macromolecular catabolic process (11).  
PANTHER molecular function analysis associated the list with glycosyltransferase, actin 
binding and cytoskelatal protein.  Kegg pathways identified were spliceosome, Fc 
gamma R-mediated phagocytosis, N-glycan biosynthesis and long term depression.  
Further filtering with the fold change of 1.5 reduced the list to 78 genes, however the 
associated biological processes identified were consistent (Table 10).  PANTHER 
molecular function only identified receptor and no Kegg pathways were flagged (data not 
shown).  
Non-rescued down-regulated genes were associated with cell cycle, mitotic cell 
cycle and cell division in GO_BP analysis as primary processes.  PANTHER molecular 
function associated 21 genes with nucleic acid binding, and others were associated with 
methyltransferases, hydrolase and “other” phosphatase.  Oocyte meiosis and ubiquitin 
mediated proteolysis were the only two Kegg pathways implicated.  Further filtering with 
a 1.5 cutoff reduced this list to only 38 genes and cell cycle was consistently identified as 
a primary GO_BP term (Table 11).  However, anatomical structure development and 
enzyme linked receptor were also terms identified.  No PANTHER molecular function or 
Kegg Pathways were associated with the fold change filtered list. 
The summary of biological function analysis reveal that Cfp1 is involved in 
multiple critical cellular processes, including cell cycle control, development and 
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biosynthetic and metabolic processes, some of which may not be rescued by Cfp1 
replacement.  
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Figure 1.  PCR products from WT and Wdr82(+/-) embryo DNA. 
A. Embryo DNA was analyzed for genotype by multiplex PCR products run on 1% 
agarose gel and identified by ethidium bromide. Size was determined by standard 100 
base pair DNA ladder.  B. Cartoon depicting Wdr82 gene location for primers used in 
multiplex PCR.  B-geo is the LacZ gene casette coding for β-galactosidase.    
   WT         Wdr82 
                     Het 
A. 
B. 
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Table 1.  Embryo genotypes in Wdr82(+/-) matings.  
Wdr82(+/-) mice were mated and embryos collected on day 9.5–11.5 dpc for DNA 
extraction.  Genotype analysis was performed by multiplex PCR amplification as 
described in materials and methods.  Amplification products were detected with ethidium 
bromide and run on 1.5% agarose gel. 
 
 
 
Time point Total Embryos  WT 
Wdr82 
Het 
Wdr82 
Nulls 
9.5-11.5 dpc 74 7 67 0 
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Figure 2.  Wdr82 Het ES cells demonstrate β-galactosidase activity. 
Asynchronous exponentially growing Wild Type (WT) and Wdr82 Het ES cells 
containing the LacZ disrupted gene trap (AZ0280) were stained for β-galactosidase 
activity in X-gal staining buffer.  Cells were observed under inverted light microscope at 
10x magnification.  β-galactosidase activity is indicated by presence of blue color. 
 
 
WT Wdr82 HET 
  35
 
                              
 
 
 
 
 
 
 
Figure 3.  Wdr82 het ES cell produce reduced levels of Wdr82 protein. 
Nuclear enriched cell lysates collected from asynchronous exponentially growing WT 
and Wdr82 Het ES cells grown in LIF to prevent differentiation were analyzed by 
Western blot with antibodies indicated.  β-actin demonstrates relative protein levels in 
sample. 
 
WT     Het 
Anti- Wdr82 
Anti- Actin 
  36
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Wdr82 Het cells exhibit earlier induction of differentiation. 
WT and Wdr82 Het ES cells were plated in ES culture media without LIF to induce 
differentiation.  Cells were monitored by light microscope in 24 hour intervals.  
Outgrowth of embroid-like bodies is indicative of differentiation. 
 
 
WT 
Wdr82 
Het 
Day 1                   Day 2                   Day 3 
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Figure 5.  Cell counts for cDNA expressing HEK 293 T-rex cells. 
HEK 293 T-rex cells were seeded in duplicate and expression induced by addition of 1 
mg/ml doxycycline.  Cells were collected at day 1, 2, 3 and 4 in 24 hour intervals.  Day 2, 
3 and 4 cell counts are shown above.  Viable cells were counted by hemocytometer with 
Trypan Blue staining under an inverted light microscope. 
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Figure 6.  Significantly reduced cell counts at day 4 with overexpression of Setd1 full 
length or truncated cDNA. 
HEK 293 T-rex cells were seeded in duplicate and expression induced by addition of 1 
mg/ml doxycycline.  Statistical analysis was performed on cell counts for day 4 shown 
above.  Viable cells were counted by hemocytometer with Trypan Blue staining under 
inverted light microscope.  * Significant difference (p<0.0001) than vector. ** Significant 
difference (p<0.005) than Setd1B, but not Setd1A.  *** Significant difference (p<0.005) 
than Setd1A, Setd1B and vector. 
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Figure 7.  Setd1 overexpression alters cell cycle. 
Stably transfected inducible HEK 293 T-rex cells were grown in media with doxycycline 
to induce gene expression.  Asynchronous exponentially growing cells were collected and 
analyzed for cell cycle by propidium iodide staining on FACScan flow cytometer as 
described in methods and materials.  * Statisitical significance p<0.01 compared to 
vector.   
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Figure 8.  CFP1(-/-) ES cell microarray data tightly cluster and separate.  
Total RNA from one wild type (WT), two distinct Cfp1(-/-) (N1 and N2) and a Cfp1 
knockout cell line (N1) transfected with human Cfp1 cDNA (WT-R) was analyzed by 
Affymetrix Mouse Genome 430 2.0 GeneChip®.  Overall Data was log transformed (base 
2) in Park Genomics Suite software for quality assessment.  A. Principal Component 
Analysis in three dimensions.  B. Heirachechal clustering of the same overall data set.
A. 
B. 
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Figure 9.  Top 100 changes in gene expression identified by p-value with one-way 
analysis of variation. 
Total RNA from one wild type (WT), two distinct CFP1 knockout (N1 and N2) and a 
CFP1 knockout cell line (N1) transfected with human CFP1cDNA (WT-R) was analyzed 
by Affymetrix Mouse Genome 430 2.0 GeneChip®.  Color scale indicates relative 
expression levels after log transformation and normalization of data as described in 
materials and methods in one-way analysis of variation. 
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Figure 10.  Top 100 changes in gene expression identified by p-value with two-way 
analysis of variation. 
Total RNA from one wild type (WT), two distinct Cfp1 knockout (N1 and N2) and a 
Cfp1 knockout cell line (N1) transfected with human Cfp1 cDNA (WT-R) was analyzed 
by Affymetrix Mouse Genome 430 2.0 GeneChip®.  Color scale indicates relative 
expression levels after log transformation and normalization of data as described in 
materials and methods in two-way analysis of variation. 
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Table 2.  Number of probes identified as statistically different in two-way ANOVA 
contrasts. 
 <.0001 <0.001 <0.01 <0.025 <0.05 <0.1 <1 
NULL * N1 vs WT * WT (N1 vs WT)     
p-value 4471 6481 9441 11041 12560 14363 26082 
q-value (FDR) 3782 6034 9403 11417 13350 16012 26085 
        
NULL * N2 vs WT * WT (N2 vs WT)     
p-value 3777 5839 8824 10507 12044 13918 26078 
q-value (FDR) 3009 5191 8505 10621 12596 15256 26085 
        
NULL * N2 vs NULL * N1 (N1 vs N2)     
p-value 2741 4361 7091 8649 10260 12290 26080 
q-value (FDR) 1866 3416 6216 7942 9854 12592 26085 
        
WT * WT-R vs WT * WT (Rescue vs WT)    
p-value 1927 3367 6035 7726 9303 11333 26080 
q-value (FDR) 1030 2199 4615 6388 8330 10825 26085 
        
NULL * N1 vs WT * WT-R (N1 vs Rescue)    
p-value 3537 5469 8431 10008 11582 13524 26082 
q-value (FDR) 2717 4681 8068 9969 12005 14765 26085 
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Table 3.  Number of probes identified as up- and down-regulated by p-value. 
Two-way ANOVA contrasts were analyzed for consistency in up and down regulation in 
N1 and N2 vs. WT and N1 vs. Rescue as described in materials and methods. 
  
No 
filter p<.05 
% 
Present p<.01 
% 
Present p<.001 
% 
Present p<.0001 
% 
Present  
N1 vs WT <0 12889 6156 23.6 4570 17.5 3140 12.0 2132 8.2 
N1 vs WT >0 13196 6410 24.6 4872 18.7 3341 12.8 2339 9.0 
Total 26085 12566 48.2 9442 36.2 6481 24.8 4471 17.1 
                
N2 vs WT <0 11939 5224 20.0 3840 14.7 2540 9.7 1662 6.4 
N2 vs WT >0 14146 6820 26.1 4984 19.1 3299 12.6 2115 8.1 
Total 26085 12044 46.2 8824 33.8 5839 22.4 3777 14.5 
                
N1 & N2 vs WT <0 8876 3307 12.7 2345 9.0 1523 5.8 958 3.7 
N1 & N2 vs WT>0 10133 4184 16.0 2972 11.4 1893 7.3 1229 4.7 
Total 19009 7491 28.7 5317 20.4 3416 13.1 2187 8.4 
                
N1 & N2 vs WT <0 = Rescue 6936 2102 8.1 1472 5.6 888 3.4 537 2.1 
N1 & N2 vs WT >0 =Rescue 7123 2542 9.7 1737 6.7 1050 4.0 653 2.5 
Total 14059 4644 17.8 3209 12.3 1938 7.4 1190 4.6 
                
N1 & N2 vs WT <0; No Rescue 1940 138 0.5 58 0.2 29 0.1 9 0.0 
N1 & N2 vs WT >0; No Rescue 3010 178 0.7 72 0.3 52 0.2 7 0.0 
Total 4950 316 1.2 130 0.5 81 0.3 16 0.1 
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Table 4.  Up-regulated Cfp1(-/- ) and rescued genes submitted for functional 
annotation analysis.  
Genes were identified using two-way ANOVA contrasts N1 vs. WT, N1 vs. Rescue and 
N2 vs. WT (p<0.0001) with fold change ≥ 1.5.   
Gene Name Description Gene Name Description 
Chromosome 1 Chromosome 3  
Vnn1 vanin 1 3200002M19Rik RIKEN cDNA 3200002M19 gene 
2310035C23Rik RIKEN cDNA 2310035C23 gene 5730508B09Rik RIKEN cDNA 5730508B09 gene 
Agfg1 ArfGAP with FG repeats 1 Adh1 alcohol dehydrogenase 1 (class I) 
Aox4 aldehyde oxidase 4 Bhlhe22 basic helix-loop-helix family, member e22 
C130073F10Rik RIKEN cDNA C130073F10 gene Crabp2 cellular retinoic acid binding protein II 
Cd55 CD55 antigen Fam198b family with sequence similarity 198, member B 
Cnst consortin, connexin sorting protein Fndc3b fibronectin type III domain containing 3B 
D630023F18Rik RIKEN cDNA D630023F18 gene Igsf3 immunoglobulin superfamily, member 3 
Ddr2 discoidin domain receptor family, member 2 Mfsd1 major facilitator superfamily domain 
containing 1 
Gpa33 glycoprotein A33 (transmembrane) Mme membrane metallo endopeptidase 
Igfbp2 insulin-like growth factor binding protein 2 Ppp3ca protein phosphatase 3, catalytic subunit, alpha 
isoform 
LOC100044384 hypothetical protein LOC100044384 Ptpn22 protein tyrosine phosphatase, non-receptor type 
22 (lymphoid) 
Msc musculin Snx16 sorting nexin 16 
Ncoa2 nuclear receptor coactivator 2 Sohlh2 spermatogenesis and oogenesis specific basic 
helix-loop-helix 2 
Pign phosphatidylinositol glycan anchor 
biosynthesis, class N 
Tlr2 toll-like receptor 2 
Prdm14 PR domain containing 14 Zbtb10 zinc finger and BTB domain containing 10 
Ren1 /// Ren2 renin 1 structural /// renin 2 tandem 
duplication of Ren1 
Chromosome 4  
Satb2 special AT-rich sequence binding protein 2 Aqp3 aquaporin 3 
Stk17b serine/threonine kinase 17b (apoptosis-
inducing) 
Btbd19 BTB (POZ) domain containing 19 
Chromosome 2 Car8 carbonic anhydrase 8 
Bmi1 Bmi1 polycomb ring finger oncogene Ckb creatine kinase, brain 
Commd3 COMM domain containing 3 Dctn3 dynactin 3 
Cst3 cystatin C Fabp3 fatty acid binding protein 3, muscle and heart 
Dpp4 dipeptidylpeptidase 4 Grhl3 grainyhead-like 3 (Drosophila) 
Meis2 Meis homeobox 2 Lpar1 lysophosphatidic acid receptor 1 
Pramel6 preferentially expressed antigen in melanoma 
like 6 
Manea mannosidase, endo-alpha 
Ptges prostaglandin E synthase Ppap2b phosphatidic acid phosphatase type 2B 
Ryr3 ryanodine receptor 3 Rpl22 ribosomal protein L22 
Serping1 serine (or cysteine) peptidase inhibitor, clade 
G, member 1 
Tek endothelial-specific receptor tyrosine kinase 
Smtnl1 smoothelin-like 1 Chromosome 5 
Spcs2 signal peptidase complex subunit 2 homolog 
(S. cerevisiae) 
Abcb1b ATP-binding cassette, sub-family B 
(MDR/TAP), member 1B 
Tfpi tissue factor pathway inhibitor Agpat9 1-acylglycerol-3-phosphate O-acyltransferase 9 
Tnfaip6 tumor necrosis factor alpha induced protein 6 Atp8a1 ATPase, aminophospholipid transporter 
(APLT), class I, type 8A, member 1 
Ube2l6 ubiquitin-conjugating enzyme E2L 6 Cox7b2 cytochrome c oxidase subunit VIIb2 
Wfdc15a WAP four-disulfide core domain 15A Cpeb2 cytoplasmic polyadenylation element binding 
protein 2 
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Table 4.  Up-regulated Cfp1(-/-) and rescued genes submitted for functional 
annotation analysis. (cont.) 
Gene Name Description Gene Name Description 
Chromosome 5 (cont.) Chromosome 7 (cont.) 
Limch1 LIM and calponin homology domains 1 Btbd10  BTB (POZ) domain containing 10  
Lrpap1 low density lipoprotein receptor-related 
protein associated protein 1 
Bub3 budding uninhibited by benzimidazoles 3 
homolog (S. cerevisiae) 
Naa11 N(alpha)-acetyltransferase 11, NatA catalytic 
subunit 
C2cd3 C2 calcium-dependent domain containing 3 
Otop1 otopetrin 1 Calm3 calmodulin 3 
Pgm1 phosphoglucomutase 1 Ceacam20  carcinoembryonic antigen-related cell adhesion 
molecule 20  
Slc5a1 solute carrier family 5 (sodium/glucose 
cotransporter), member 1 
Cib1 calcium and integrin binding 1 (calmyrin) 
Tbx3 T-box 3 Ctr9 Ctr9, Paf1/RNA polymerase II complex 
component, homolog (S. cerevisiae) 
Ulk1 Unc-51 like kinase 1 (C. elegans) Cttn cortactin 
Chromosome 6 Dcun1d3 DCN1, defective in cullin neddylation 1, 
domain containing 3 (S. cerevisiae) 
A2m  alpha-2-macroglobulin  Dhx32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 
Aebp2 AE binding protein 2 Dmwd dystrophia myotonica-containing WD repeat 
motif 
Asz1 ankyrin repeat, SAM and basic leucine zipper 
domain containing 1 
Fam169b family with sequence similarity 169, member B 
Eps8 epidermal growth factor receptor pathway 
substrate 8 
Fam175b family with sequence similarity 175, member B 
Hipk2 homeodomain interacting protein kinase 2 Far1 fatty acyl CoA reductase 1 
Ldhb lactate dehydrogenase B Fgf4 fibroblast growth factor 4 
Rimklb ribosomal modification protein rimK-like 
family member B 
Fgfr2 fibroblast growth factor receptor 2 
Mdfic MyoD family inhibitor domain containing Folr1 folate receptor 1 (adult) 
Mfap5 microfibrillar associated protein 5 Folr2 folate receptor 2 (fetal) 
Pzp pregnancy zone protein Fxyd5 FXYD domain-containing ion transport 
regulator 5 
Slc35b4 solute carrier family 35, member B4 Gde1 glycerophosphodiester phosphodiesterase 1 
Ube2h ubiquitin-conjugating enzyme E2H Polr2l /// Usp50 polymerase (RNA) II (DNA directed) 
polypeptide L /// ubiquitin specific peptidase 50 
Zc3hav1 zinc finger CCCH type, antiviral 1 Gramd1a GRAM domain containing 1A 
Zxdc ZXD family zinc finger C H19 H19 fetal liver mRNA 
Chromosome 7 H47 histocompatibility 47 
2210018M11Rik RIKEN cDNA 2210018M11 gene Hdgfrp3 hepatoma-derived growth factor, related protein 
3 
LOC100047683 hypothetical protein LOC100047683 Hps5 Hermansky-Pudlak syndrome 5 homolog 
(human) 
6330503K22Rik RIKEN cDNA 6330503K22 gene Htatip2 HIV-1 tat interactive protein 2, homolog 
(human) 
9030624J02Rik RIKEN cDNA 9030624J02 gene Htra1 HtrA serine peptidase 1 
Alg8 asparagine-linked glycosylation 8 homolog 
(yeast, alpha-1,3-glucosyltransferase) 
Idh2 isocitrate dehydrogenase 2 (NADP+), 
mitochondrial 
Arrdc4 arrestin domain containing 4 Igf1r insulin-like growth factor I receptor 
Ate1 arginyltransferase 1 Kctd15 potassium channel tetramerisation domain 
containing 15 
AU018091 expressed sequence AU018091 Kndc1 kinase non-catalytic C-lobe domain (KIND) 
containing 1 
Aurkc aurora kinase C Ldhc lactate dehydrogenase C 
B230311B06Rik RIKEN cDNA B230311B06 gene Lrrc28 leucine rich repeat containing 28 
BC066028 cDNA sequence BC066028 Lsm14a LSM14 homolog A (SCD6, S. cerevisiae) 
Bola2 bolA-like 2 (E. coli) Mex3b mex3 homolog B (C. elegans) 
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Table 4.  Up-regulated Cfp1(-/-) and rescued genes submitted for functional 
annotation analysis. (cont.) 
Gene Name Description Gene Name Description 
Chromosome 7 (cont.) Chromosome 8 (cont.) 
Mfge8 milk fat globule-EGF factor 8 protein Col4a2 collagen, type IV, alpha 2 
Mrpl23 mitochondrial ribosomal protein L23 Dlc1 deleted in liver cancer 1 
Mrpl46 mitochondrial ribosomal protein L46 Hgsnat heparan-alpha-glucosaminide N-
acetyltransferase 
Mtmr10 myotubularin related protein 10 Hpgd hydroxyprostaglandin dehydrogenase 15 
(NAD) 
Ndufa3 NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex, 3 
Lpl lipoprotein lipase 
Ndufc2 NADH dehydrogenase (ubiquinone) 1, 
subcomplex unknown, 2 
Nqo1 NAD(P)H dehydrogenase, quinone 1 
Nfatc2ip nuclear factor of activated T-cells, 
cytoplasmic, calcineurin-dependent 2 
interacting protein 
Slc35f3 solute carrier family 35, member F3 
Nlrp4c NLR family, pyrin domain containing 4C 2410076I21Rik RIKEN cDNA 2410076I21 gene 
Pdcd2l programmed cell death 2-like 9030425E11Rik RIKEN cDNA 9030425E11 gene 
Pih1d1 PIH1 domain containing 1 Chromosome 9 
Pik3c2a phosphatidylinositol 3-kinase, C2 domain 
containing, alpha polypeptide 
BC031353 cDNA sequence BC031353 
Ppp1r14a protein phosphatase 1, regulatory (inhibitor) 
subunit 14A 
Ccpg1 cell cycle progression 1 
Prr14 proline rich 14 Gm5918 predicted gene 5918 
Rab30 RAB30, member RAS oncogene family Gsta1 /// Gsta2 glutathione S-transferase, alpha 1 (Ya) /// 
glutathione S-transferase, alpha 2 (Yc2) 
Rabac1 Rab acceptor 1 (prenylated) Lrrc2 leucine rich repeat containing 2 
Rbm42 RNA binding motif protein 42 Rab27a RAB27A, member RAS oncogene family 
Rhpn2 rhophilin, Rho GTPase binding protein 2 Smad6 MAD homolog 6 (Drosophila) 
Rnf121 ring finger protein 121 Spa17 sperm autoantigenic protein 17 
Rsf1 remodeling and spacing factor 1 Spesp1 sperm equatorial segment protein 1 
Saa3 serum amyloid A 3 Tmem41b transmembrane protein 41B 
Saal1 serum amyloid A-like 1 Gsta1 /// Gsta2 glutathione S-transferase, alpha 1 (Ya) /// 
glutathione S-transferase, alpha 2 (Yc2) 
Sars2 seryl-aminoacyl-tRNA synthetase 2 Lrrc2 leucine rich repeat containing 2 
Siglec5 sialic acid binding Ig-like lectin 5 Rab27a RAB27A, member RAS oncogene family 
Syce1 synaptonemal complex central element protein 
1 
Smad6 MAD homolog 6 (Drosophila) 
Tead1 TEA domain family member 1 Spa17 sperm autoantigenic protein 17 
Tfpt TCF3 (E2A) fusion partner Spesp1 sperm equatorial segment protein 1 
Tmc7 transmembrane channel-like gene family 7 Tmem41b transmembrane protein 41B 
Tnnt1 troponin T1, skeletal, slow Chromosome 10 
Tubgcp2 tubulin, gamma complex associated protein 2 AI317395 expressed sequence AI317395 
Wdr11 WD repeat domain 11 Chpt1 choline phosphotransferase 1 
Wdr62 WD repeat domain 62 Ipmk inositol polyphosphate multikinase 
Zbtb45 zinc finger and BTB domain containing 45 Kitl kit ligand 
Zfp264 zinc finger protein 264 LOC100047324 /// 
Sesn1 
similar to Sesn1 protein /// sestrin 1 
Zfp689 zinc finger protein 689 Map3k5 mitogen-activated protein kinase kinase kinase 
5 
Zfp74 zinc finger protein 74 Psap prosaposin 
Chromosome 8 Rbms2 RNA binding motif, single stranded interacting 
protein 2 
Ccl25 chemokine (C-C motif) ligand 25 Spic Spi-C transcription factor (Spi-1/PU.1 related) 
Col4a1 collagen, type IV, alpha 1 Txlnb taxilin beta 
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Table 4.  Up-regulated Cfp1(-/-) and rescued genes submitted for functional 
annotation analysis. (cont.) 
Gene Name Description Gene Name Description 
Chromosome 11  Chromosome 11 (cont.) 
1500010J02Rik RIKEN cDNA 1500010J02 gene Sparc secreted acidic cysteine rich glycoprotein 
1700042O10Rik RIKEN cDNA 1700042O10 gene Stat5a signal transducer and activator of transcription 
5A 
2210409E12Rik transcription elongation factor B (SIII), 
polypeptide 2 pseudogene 
Suz12 suppressor of zeste 12 homolog (Drosophila) 
3010026O09Rik RIKEN cDNA 3010026O09 gene Tekt1 tektin 1 
4933427D14Rik RIKEN cDNA 4933427D14 gene Tex19.2 testis expressed gene 19.2 
Akap1 A kinase (PRKA) anchor protein 1 Trim41 tripartite motif-containing 41 
Appbp2 amyloid beta precursor protein (cytoplasmic 
tail) binding protein 2 
Ube2b ubiquitin-conjugating enzyme E2B, RAD6 
homology (S. cerevisiae) 
Aspa aspartoacylase Urgcp upregulator of cell proliferation 
Atp1b2 ATPase, Na+/K+ transporting, beta 2 
polypeptide 
Utp6 UTP6, small subunit (SSU) processome 
component, homolog (yeast) 
C1d C1D nuclear receptor co-repressor Vps53 vacuolar protein sorting 53 (yeast) 
Cbx4 chromobox homolog 4 (Drosophila Pc class) Wrap53 WD repeat containing, antisense to TP53 
Cct4 chaperonin containing Tcp1, subunit 4 (delta) Wsb1 WD repeat and SOCS box-containing 1 
Cct4 chaperonin containing Tcp1, subunit 4 (delta) Xbp1 X-box binding protein 1 
Cpeb4 cytoplasmic polyadenylation element binding 
protein 4 
Chromosome 12 
Ddc dopa decarboxylase Frmd6 FERM domain containing 6 
Derl2 Der1-like domain family, member 2 Gtf2a1 general transcription factor II A, 1 
Dynll2 dynein light chain LC8-type 2 Sec23a SEC23A (S. cerevisiae) 
Fam183b family with sequence similarity 183, member 
B 
Six4 sine oculis-related homeobox 4 homolog 
(Drosophila) 
Ggnbp2 Gametogenetin binding protein 2 Uevld UEV and lactate/malate dehyrogenase domains 
H2afv H2A histone family, member V Chromosome 13 
Krt12 keratin 12 Akr1c12/c13 aldo-keto reductase family 1, member C12 
/C13 
Lig3 ligase III, DNA, ATP-dependent Ccno cyclin O 
Llgl2  lethal giant larvae homolog 2 (Drosophila)  Fbp2 fructose bisphosphatase 2 
Lsmd1 LSM domain containing 1 Gadd45g growth arrest and DNA-damage-inducible 45 
gamma 
Med13 mediator complex subunit 13 Hist1h2bp  histone cluster 1, H2bp /// similar to Hist1h2bj 
protein 
Meis1 Meis homeobox 1 Hist1h1c histone cluster 1, H1c 
Mis12 MIS12 homolog (yeast) Hist1h2bc histone cluster 1, H2bc 
Mrm1 mitochondrial rRNA methyltransferase 1 
homolog (S. cerevisiae) 
Id4  inhibitor of DNA binding 4  
Mrps24 mitochondrial ribosomal protein S24 Lyst lysosomal trafficking regulator 
Nbr1 neighbor of Brca1 gene 1 Nid1 nidogen 1 
Ncor1 nuclear receptor co-repressor 1 Nlrp4f NLR family, pyrin domain containing 4F 
Pecam1 platelet/endothelial cell adhesion molecule 1 Ppap2a phosphatidic acid phosphatase type 2A 
Sept8 septin 8 Chromosome 14 
Slc35b1 solute carrier family 35, member B1 Gm7233  predicted gene 7233  
Slc43a2 solute carrier family 43, member 2 D14Ertd436e DNA segment, Chr 14, ERATO Doi 436, 
expressed 
Slc46a1 solute carrier family 46, member 1 Defb42 defensin beta 42 
Smtnl2 smoothelin-like 2 LOC624112 hypothetical protein LOC624112 
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Table 4.  Up-regulated Cfp1(-/-) and rescued genes submitted for functional 
annotation analysis. (cont.) 
Gene Name Description Gene Name Description 
Chromosome 14 (cont.) Chromosome 19 (cont.) 
Hesx1 homeobox gene expressed in ES cells Crtac1 cartilage acidic protein 1 
Sox21 SRY-box containing gene 21 Ldhb lactate dehydrogenase B 
Chromosome 15 Mbl2 mannose-binding lectin (protein C) 2 
Aard alanine and arginine rich domain containing 
protein 
Mlana melan-A 
Creld2 cysteine-rich with EGF-like domains 2 Ms4a10 membrane-spanning 4-domains, subfamily A, 
member 10 
Dab2 disabled homolog 2 (Drosophila) Pga5 pepsinogen 5, group I 
Gtsf1 gametocyte specific factor 1 Saps3 SAPS domain family, member 3 
Myo10 myosin X Chromosome X 
Sepp1 selenoprotein P, plasma, 1 1700013H16Rik RIKEN cDNA 1700013H16 gene 
Chromosome 16 4933402E13Rik RIKEN cDNA 4933402E13 gene 
Abcc5 ATP-binding cassette, sub-family C 
(CFTR/MRP), member 5 
Abcd1 ATP-binding cassette, sub-family D (ALD), 
member 1 
Alcam activated leukocyte cell adhesion molecule Pramel3 preferentially expressed antigen in melanoma-
like 3 
Brwd1 bromodomain and WD repeat domain 
containing 1 
Dcaf12l1 DDB1 and CUL4 associated factor 12-like 1 
Cd200 CD200 antigen Dmrtc1c  DMRT-like family C1c /// DMRT-like family 
C1c2 
Lrrc15 leucine rich repeat containing 15 Efhc2 EF-hand domain (C-terminal) containing 2 
Chromosome 17 Fgd1 FYVE, RhoGEF and PH domain containing 1 
Cdc42ep3 CDC42 effector protein (Rho GTPase binding) 
3 
Fthl17  ferritin, heavy polypeptide-like 17  
Dazl deleted in azoospermia-like Gm7365 predicted gene 2012  
Lclat1 lysocardiolipin acyltransferase 1 Luzp4 /// Ott  leucine zipper protein 4 /// ovary testis 
transcribed  
Ly6g6e lymphocyte antigen 6 complex, locus G6E Gm9 predicted gene 9 
Qpct glutaminyl-peptide cyclotransferase 
(glutaminyl cyclase) 
Hdac6 histone deacetylase 6 
Tnfrsf21 tumor necrosis factor receptor superfamily, 
member  
Itm2a integral membrane protein 2A 
Tulp4 tubby like protein 4 Scml2 sex comb on midleg-like 2 (Drosophila) 
Ypel5 yippee-like 5 (Drosophila) Nxf3 nuclear RNA export factor 3 
Chromosome 18 Rhox13 reproductive homeobox 13 
Atg12 autophagy-related 12 (yeast) Rhox2a reproductive homeobox 2A 
Cidea cell death-inducing DNA fragmentation factor, 
alpha subunit-like effector A 
Rhox4 reproductive homeobox 4A  
Cndp2 CNDP dipeptidase 2 (metallopeptidase M20 
family) 
Tsx testis specific X-linked gene 
Dpysl3 dihydropyrimidinase-like 3 Usp9x ubiquitin specific peptidase 9, X chromosome 
Prrc1 proline-rich coiled-coil 1 Xlr3a/b/c X-linked lymphocyte-regulated 3A/3B/3C 
Slc12a2 solute carrier family 12, member 2 Xlr4a/b/c X-linked lymphocyte-regulated 4A/4B/4C 
Chromosome 19 Zfp711 zinc finger protein 711 
Cpn1 carboxypeptidase N, polypeptide 1   
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Table 5.  Down-regulated Cfp1(-/-) and rescued genes submitted for functional 
annotation analysis. 
Genes were identified using two-way ANOVA contrasts N1 vs. WT, N1 vs. Rescue and 
N2 vs. WT (p<0.0001) and fold changes ≤ -1.5.  
Gene Name Description Gene Name Description 
Chromosome 1 Chromosome 3 
Mtm1 X-linked myotubular myopathy gene 1 Adar adenosine deaminase, RNA-specific 
Pstpip2 proline-serine-threonine phosphatase-interacting 
protein 2 
Bdh2 3-hydroxybutyrate dehydrogenase, type 2 
Adam23 a disintegrin and metallopeptidase domain 23 Fubp1 far upstream element (FUSE) binding protein 1 
Aldh9a1 aldehyde dehydrogenase 9, subfamily A1 Isg20l2 interferon stimulated exonuclease gene 20-like 2 
Ccnt2 cyclin T2 Nras neuroblastoma ras oncogene 
Chml choroideremia-like Mllt11 myeloid/lymphoid or mixed-lineage leukemia 
(trithorax homolog, Drosophila); translocated to, 
11 
Gas5 growth arrest specific 5 Phf17 PHD finger protein 17 
Snord47 small nucleolar RNA, C/D box 47 Pitx2 paired-like homeodomain transcription factor 2 
Gbx2 gastrulation brain homeobox 2 Ppm1j protein phosphatase 1J 
Gli2 GLI-Kruppel family member GLI2 Prpf3 PRP3 pre-mRNA processing factor 3 homolog 
(yeast) 
Inhbb  inhibin beta-B  Psrc1 proline/serine-rich coiled-coil 1 
Slc39a10 solute carrier family 39 (zinc transporter), 
member 10 
Rabggtb RAB geranylgeranyl transferase, b subunit 
Sulf1 sulfatase 1 Sars seryl-aminoacyl-tRNA synthetase 
Tuba4a tubulin, alpha 4A Snhg8 small nucleolar RNA host gene 8 
Chromosome 2 Stmn2 stathmin-like 2 
1500012F01Rik RIKEN cDNA 1500012F01 gene Trim2 tripartite motif-containing 2 
Accsl 1-aminocyclopropane-1-carboxylate synthase 
homolog (Arabidopsis)(non-functional)-like 
Chromosome 4 
Cdca7 cell division cycle associated 7 D4Wsu53e DNA segment, Chr 4, Wayne State University 
53, expressed 
Chac1 ChaC, cation transport regulator-like 1 (E. coli) Ddx58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 
Csrnp3 cysteine-serine-rich nuclear protein 3 Lck lymphocyte protein tyrosine kinase 
Ell3 elongation factor RNA polymerase II-like 3 Rcc1 regulator of chromosome condensation 1 
Glo1 glyoxalase 1 Snhg12 small nucleolar RNA host gene 12 
Id1 inhibitor of DNA binding 1 Snhg3 small nucleolar RNA host gene (non-protein 
coding) 3 
Mcm10 minichromosome maintenance deficient 10 (S. 
cerevisiae) 
Tomm5 translocase of outer mitochondrial membrane 5 
homolog (yeast) 
Mcts2 malignant T cell amplified sequence 2 Chromosome 5 
Mettl11a methyltransferase like 11A 2210408K08Rik RIKEN cDNA 2210408K08 gene 
Pdk1 pyruvate dehydrogenase kinase, isoenzyme 1 2700023E23Rik RIKEN cDNA 2700023E23 gene 
Pim2 proviral integration site 2 Atp10d ATPase, class V, type 10D 
Plcb4 phospholipase C, beta 4 Cabp1 calcium binding protein 1 
Qser1 glutamine and serine rich 1 Cnpy1 canopy 1 homolog (zebrafish) 
Rpl12 ribosomal protein L12 Crmp1 collapsin response mediator protein 1 
Snhg7 Small nucleolar RNA host gene (non-protein 
coding) 7 
Fgfbp1 fibroblast growth factor binding protein 1 
Spred1 sprouty protein with EVH-1 domain 1, related 
sequence 
Gtf2i general transcription factor II I 
Surf2 surfeit gene 2 Pla2g1b phospholipase A2, group IB, pancreas 
Tdh L-threonine dehydrogenase Slc7a1 solute carrier family 7 (cationic amino acid 
transporter, y+ system), member 1 
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Table 5.  Down-regulated Cfp1(-/-) and rescued genes submitted for functional 
annotation analysis. (cont.) 
Gene Name Description Gene Name Description 
Chromosome 6 Chromsome 8 (cont.) 
Uba6 ubiquitin-like modifier activating enzyme 6 Pgls 6-phosphogluconolactonase 
8430410A17Rik RIKEN cDNA 8430410A17 gene Prdx2 peroxiredoxin 2 
Bcat1 branched chain aminotransferase 1, cytosolic Setd6 SET domain containing 6 
Bid BH3 interacting domain death agonist Tfdp1 transcription factor Dp 1 
Fgd5 FYVE, RhoGEF and PH domain containing 5 Xkr5 X Kell blood group precursor-related family, 
member 5 
Foxp1 forkhead box P1 Zfp423 zinc finger protein 423 
Gars glycyl-tRNA synthetase Chromosome 9 
Isy1 ISY1 splicing factor homolog (S. cerevisiae) 2610101N10Rik RIKEN cDNA 2610101N10 gene 
Mthfd2 methylenetetrahydrofolate dehydrogenase 
(NAD+ dependent), methenyltetrahydrofolate 
cyclohydrolase 
2810026P18Rik RIKEN cDNA 2810026P18 gene 
Pon2 paraoxonase 2 A230050P20Rik RIKEN cDNA A230050P20 gene 
Tia1 cytotoxic granule-associated RNA binding 
protein 1 
Ap1m2 adaptor protein complex AP-1, mu 2 subunit 
Tpi1 triosephosphate isomerase 1 AW552889 expressed sequence AW552889 
Trh thyrotropin releasing hormone Calml4 calmodulin-like 4 
Chromosome 7 Exosc7 exosome component 7 
Aplp1 amyloid beta (A4) precursor-like protein 1 Hspa8  heat shock protein  
Igf2 insulin-like growth factor 2 Ppan peter pan homolog (Drosophila) 
Ino80e INO80 complex subunit E Rps25 ribosomal protein S25 
Nupr1 nuclear protein 1 Slc25a38 solute carrier family 25, member 38 
Rps9 ribosomal protein S9 Taf1d TATA box binding protein (Tbp)-associated 
factor, RNA polymerase I, D 
Chromosome 8 Tagln transgelin 
Aars alanyl-tRNA synthetase Chromosome 10 
Ankrd10 ankyrin repeat domain 10 Cdk4  cyclin-dependent kinase 4  
Aprt adenine phosphoribosyl transferase Cpsf6 cleavage and polyadenylation specific factor 6 
Arl2bp ADP-ribosylation factor-like 2 binding protein Gstt2 glutathione S-transferase, theta 2 
Arrdc2 arrestin domain containing 2 Pcbd1 pterin 4 alpha carbinolamine 
dehydratase/dimerization cofactor of hepatocyte 
nuclear factor 1 alpha (TCF1) 1 
Cotl1 coactosin-like 1 (Dictyostelium) Ric8b resistance to inhibitors of cholinesterase 8 
homolog B (C. elegans) 
Dhodh dihydroorotate dehydrogenase Rpl41 ribosomal protein L41 
Gm10664 predicted gene 10664 Timm8a1 translocase of inner mitochondrial membrane 8 
homolog a1 (yeast) 
Herpud1 homocysteine-inducible, endoplasmic reticulum 
stress-inducible, ubiquitin-like domain member 
1 
Chromosome 11 
Ier2 immediate early response 2 Aldoc aldolase C, fructose-bisphosphate 
Ifi30 interferon gamma inducible protein 30 Bahcc1 BAH domain and coiled-coil containing 1 
Slc7a5 solute carrier family 7 (cationic amino acid 
transporter, y+ system), member 5 
Coasy Coenzyme A synthase 
Lphn1 latrophilin 1 Glul glutamate-ammonia ligase (glutamine synthetase) 
Naf1 nuclear assembly factor 1 homolog (S. 
cerevisiae) 
Grb7 growth factor receptor bound protein 7 
Ncan neurocan Ntn1 netrin 1 
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Table 5.  Down-regulated Cfp1(-/-) and rescued genes submitted for functional 
annotation analysis. (cont.) 
Gene Name Description Gene Name Description 
Chromosome 11 (cont.) Chromosome 15 
Psme2 proteasome (prosome, macropain) 28 subunit, 
beta 
Arhgap8 Rho GTPase activating protein 8 
Slc16a3 solute carrier family 16 (monocarboxylic acid 
transporters), member 3 
Atf4 activating transcription factor 4 
Tk1 thymidine kinase 1 Rpl3 ribosomal protein L3 
Chromosome 12 Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 
4933433P14Rik RIKEN cDNA 4933433P14 gene Mtss1 metastasis suppressor 1 
Alkbh1 alkB, alkylation repair homolog 1 (E. coli) Myg1 melanocyte proliferating gene 1 
Bnip3l BCL2/adenovirus E1B interacting protein 3-like Naprt1 nicotinate phosphoribosyltransferase domain 
containing 1 
Crip1 cysteine-rich protein 1 (intestinal) Pvt1 plasmacytoma variant translocation 1 
G2e3 G2/M-phase specific E3 ubiquitin ligase   
Gm71 predicted gene 71 Smagp small cell adhesion glycoprotein 
Itpk1 inositol 1,3,4-triphosphate 5/6 kinase Zfp740 zinc finger protein 740 
Chromosome 13 Chromosome 16 
AA987161 expressed sequence AA987161 2510002D24Rik RIKEN cDNA 2510002D24 gene 
AW209491 expressed sequence AW209491 Bdh1 3-hydroxybutyrate dehydrogenase, type 1 
Cdc14b CDC14 cell division cycle 14 homolog B (S. 
cerevisiae) 
Cbr3 carbonyl reductase 3 
E2f3 E2F transcription factor 3 Dtx3l deltex 3-like (Drosophila) 
Emb embigin Gap43 growth associated protein 43 
F2rl1 coagulation factor II (thrombin) receptor-like 1 Nit2 nitrilase family, member 2 
Idi1 isopentenyl-diphosphate delta isomerase Srl sarcalumenin 
Iqgap2 IQ motif containing GTPase activating protein 2 Chromosome 17 
Sfxn1 sideroflexin 1 1110038B12Rik RIKEN cDNA 1110038B12 gene 
Chromosome 14 1700097N02Rik RIKEN cDNA 1700097N02 gene 
Adk adenosine kinase 1700097N02Rik RIKEN cDNA 1700097N02 gene 
AU020094 expressed sequence AU020094 2610019E17Rik RIKEN cDNA 2610019E17 gene 
Bmp4 bone morphogenetic protein 4 Bst2 bone marrow stromal cell antigen 2 
Cryl1 crystallin, lambda 1 Crb3 crumbs homolog 3 (Drosophila) 
Fgf17 fibroblast growth factor 17 Dnahc8 dynein, axonemal, heavy chain 8 
Gng2 guanine nucleotide binding protein (G protein), 
gamma 2 
Ehmt2 euchromatic histone lysine N-methyltransferase 2 
Gnl3 guanine nucleotide binding protein-like 3 
(nucleolar) 
Gm7325 predicted gene 7325 
Pnp purine-nucleoside phosphorylase H2-D1 histocompatibility 2, D region locus 1 
Lpar6 lysophosphatidic acid receptor 6 Ltb lymphotoxin B 
N6amt2 N-6 adenine-specific DNA methyltransferase 2 
(putative) 
Ppil1 peptidylprolyl isomerase (cyclophilin)-like 1 
Pck2 phosphoenolpyruvate carboxykinase 2 
(mitochondrial) 
Psmb8 proteasome (prosome, macropain) subunit, beta 
type 8 (large multifunctional peptidase 7) 
Ppif peptidylprolyl isomerase F (cyclophilin F) Srbd1 S1 RNA binding domain 1 
Rnase4 ribonuclease, RNase A family 4 Stap2 signal transducing adaptor family member 2 
Slc7a7 solute carrier family 7 (cationic amino acid 
transporter, y+ system), member 7 
T brachyury 
Tgm1 transglutaminase 1, K polypeptide Tubb5 tubulin, beta 5 
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Table 5.  Down-regulated Cfp1(-/-) and rescued genes submitted for functional 
annotation analysis. (cont.) 
Gene Name Description Gene Name Description 
Chromosome 18 Chromosome 19 (cont.) 
Celf4 CUGBP, Elav-like family member 4 Nolc1 nucleolar and coiled-body phosphoprotein 1 
Cxxc1 CXXC finger 1 (PHD domain) Pola2 polymerase (DNA directed), alpha 2 
Impact imprinted and ancient Psat1 phosphoserine aminotransferase 1 
Nars asparaginyl-tRNA synthetase Rasgrp2 RAS, guanyl releasing protein 2 
Spry4 sprouty homolog 4 (Drosophila) Scd2 stearoyl-Coenzyme A desaturase 2 
Zfp532 zinc finger protein 532 Snhg1 small nucleolar RNA host gene (non-protein 
coding) 1 
Chromosome 19 Sssca1 Sjogren's syndrome/scleroderma autoantigen 1 
homolog (human) 
5033414D02Rik RIKEN cDNA 5033414D02 gene Tmem180 transmembrane protein 180 
5730408K05Rik RIKEN cDNA 5730408K05 gene Chromosome X  
Aldh18a1 aldehyde dehydrogenase 18 family, member A1 Mageh1 melanoma antigen, family H, 1 
Gna14 guanine nucleotide binding protein, alpha 14 Mid1ip1 Mid1 interacting protein 1 (gastrulation specific 
G12-like (zebrafish)) 
Gng3 guanine nucleotide binding protein (G protein), 
gamma 3 
Rbm3 RNA binding motif protein 3 
Ina internexin neuronal intermediate filament 
protein, alpha 
Utp14a UTP14, U3 small nucleolar ribonucleoprotein, 
homolog A (yeast) 
Ms4a4d membrane-spanning 4-domains, subfamily A, 
member 4D 
Xist inactive X specific transcripts 
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 Table 6.  Gene Ontology biological process associations for Cfp1(-/-) down-regulated 
genes that rescued.  
Term for down regulated genes Count % p-Value 
GO:0009987~cellular process 132 57.641921 1.25E-05 
GO:0008152~metabolic process 100 43.668122 0.0021982 
GO:0044237~cellular metabolic process 90 39.30131 3.51E-04 
GO:0044238~primary metabolic process 87 37.991266 0.0118329 
GO:0006807~nitrogen compound metabolic process 56 24.454148 6.17E-04 
GO:0006139~nucleobase, nucleoside, nucleotide and nucleic acid metabolic process 49 21.39738 0.0031946 
GO:0044249~cellular biosynthetic process 49 21.39738 0.0062893 
GO:0010467~gene expression 42 18.340611 0.0144805 
GO:0019222~regulation of metabolic process 42 18.340611 0.0958428 
GO:0010468~regulation of gene expression 37 16.157205 0.0579591 
GO:0048518~positive regulation of biological process 27 11.790393 0.019821 
GO:0048522~positive regulation of cellular process 26 11.353712 0.0084352 
GO:0048519~negative regulation of biological process 25 10.917031 0.0164717 
GO:0048523~negative regulation of cellular process 22 9.6069869 0.0316062 
GO:0016070~RNA metabolic process 18 7.860262 0.0015624 
GO:0006082~organic acid metabolic process 17 7.4235808 1.28E-04 
GO:0042127~regulation of cell proliferation 17 7.4235808 4.61E-04 
GO:0006915~apoptosis 16 6.9868996 2.98E-04 
GO:0012501~programmed cell death 16 6.9868996 3.57E-04 
GO:0019752~carboxylic acid metabolic process 16 6.9868996 4.08E-04 
GO:0043436~oxoacid metabolic process 16 6.9868996 4.08E-04 
GO:0042180~cellular ketone metabolic process 16 6.9868996 5.28E-04 
GO:0010941~regulation of cell death 16 6.9868996 0.002075 
GO:0042981~regulation of apoptosis 15 6.5502183 0.0045818 
GO:0006396~RNA processing 14 6.1135371 0.001579 
GO:0031325~positive regulation of cellular metabolic process 14 6.1135371 0.0340832 
GO:0009893~positive regulation of metabolic process 14 6.1135371 0.0504446 
GO:0010604~positive regulation of macromolecule metabolic process 13 5.6768559 0.0603003 
GO:0009888~tissue development 13 5.6768559 0.0632021 
GO:0009966~regulation of signal transduction 13 5.6768559 0.07774 
GO:0010557~positive regulation of macromolecule biosynthetic process 12 5.2401747 0.0416776 
GO:0031328~positive regulation of cellular biosynthetic process 12 5.2401747 0.0529787 
GO:0009891~positive regulation of biosynthetic process 12 5.2401747 0.05581 
GO:0044085~cellular component biogenesis 12 5.2401747 0.0986113 
GO:0044271~nitrogen compound biosynthetic process 11 4.8034934 0.002545 
GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic 
acid metabolic process 11 4.8034934 0.0689631 
GO:0051173~positive regulation of nitrogen compound metabolic process 11 4.8034934 0.0808926 
GO:0009892~negative regulation of metabolic process 11 4.8034934 0.0873094 
GO:0006519~cellular amino acid and derivative metabolic process 10 4.3668122 0.0072935 
GO:0006066~alcohol metabolic process 10 4.3668122 0.0230176 
GO:0045941~positive regulation of transcription 10 4.3668122 0.0962266 
GO:0043066~negative regulation of apoptosis 9 3.930131 0.0063336 
GO:0043069~negative regulation of programmed cell death 9 3.930131 0.007139 
GO:0060548~negative regulation of cell death 9 3.930131 0.00731 
GO:0044106~cellular amine metabolic process 9 3.930131 0.009401 
GO:0055086~nucleobase, nucleoside and nucleotide metabolic process 9 3.930131 0.0124141 
GO:0008284~positive regulation of cell proliferation 9 3.930131 0.0167123 
GO:0006412~translation 9 3.930131 0.0307495 
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Table 6.  Gene Ontology biological process associations for Cfp1(-/-) down-regulated 
genes that rescued. (cont.) 
Term for down regulated genes Count % p-Value 
GO:0009308~amine metabolic process 9 3.930131 0.0398702 
GO:0006520~cellular amino acid metabolic process 8 3.4934498 0.0064871 
GO:0006753~nucleoside phosphate metabolic process 8 3.4934498 0.0238081 
GO:0010942~positive regulation of cell death 8 3.4934498 0.0261892 
GO:0006397~mRNA processing 8 3.4934498 0.0314299 
GO:0032787~monocarboxylic acid metabolic process 8 3.4934498 0.0348911 
GO:0048534~hemopoietic or lymphoid organ development 8 3.4934498 0.0432378 
GO:0046483~heterocycle metabolic process 8 3.4934498 0.047492 
GO:0002520~immune system development 8 3.4934498 0.0535684 
GO:0016071~mRNA metabolic process 8 3.4934498 0.0592693 
GO:0044262~cellular carbohydrate metabolic process 8 3.4934498 0.082595 
GO:0006006~glucose metabolic process 7 3.0567686 0.0055005 
GO:0019318~hexose metabolic process 7 3.0567686 0.0132642 
GO:0005996~monosaccharide metabolic process 7 3.0567686 0.0227693 
GO:0034660~ncRNA metabolic process 7 3.0567686 0.028834 
GO:0008283~cell proliferation 7 3.0567686 0.0650799 
GO:0043065~positive regulation of apoptosis 7 3.0567686 0.0660918 
GO:0043068~positive regulation of programmed cell death 7 3.0567686 0.0681429 
GO:0035295~tube development 7 3.0567686 0.0835298 
GO:0046394~carboxylic acid biosynthetic process 6 2.6200873 0.0231658 
GO:0006732~coenzyme metabolic process 6 2.6200873 0.024439 
GO:0010608~posttranscriptional regulation of gene expression 6 2.6200873 0.0278077 
GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic 
process 6 2.6200873 0.0552934 
GO:0051186~cofactor metabolic process 6 2.6200873 0.0584643 
GO:0009119~ribonucleoside metabolic process 5 2.1834061 0.0010015 
GO:0009116~nucleoside metabolic process 5 2.1834061 0.0038468 
GO:0030324~lung development 5 2.1834061 0.0387928 
GO:0048872~homeostasis of number of cells 5 2.1834061 0.0409918 
GO:0060541~respiratory system development 5 2.1834061 0.0543278 
GO:0022613~ribonucleoprotein complex biogenesis 5 2.1834061 0.0727601 
GO:0046128~purine ribonucleoside metabolic process 4 1.7467249 0.0025079 
GO:0008652~cellular amino acid biosynthetic process 4 1.7467249 0.0138896 
GO:0043039~tRNA aminoacylation 4 1.7467249 0.0156582 
GO:0045619~regulation of lymphocyte differentiation 4 1.7467249 0.0288267 
GO:0009309~amine biosynthetic process 4 1.7467249 0.0513906 
GO:0043523~regulation of neuron apoptosis 4 1.7467249 0.0641299 
GO:0017038~protein import 4 1.7467249 0.0680135 
GO:0021915~neural tube development 4 1.7467249 0.0699946 
GO:0019882~antigen processing and presentation 4 1.7467249 0.0781762 
GO:0006916~anti-apoptosis 4 1.7467249 0.0802844 
GO:0048754~branching morphogenesis of a tube 4 1.7467249 0.0911891 
GO:0006094~gluconeogenesis 3 1.3100437 0.0216753 
GO:0021532~neural tube patterning 3 1.3100437 0.0305627 
GO:0006090~pyruvate metabolic process 3 1.3100437 0.0329746 
GO:0019319~hexose biosynthetic process 3 1.3100437 0.0329746 
GO:0019362~pyridine nucleotide metabolic process 3 1.3100437 0.0406344 
GO:0021983~pituitary gland development 3 1.3100437 0.0433227 
GO:0046364~monosaccharide biosynthetic process 3 1.3100437 0.0488909 
GO:0046165~alcohol biosynthetic process 3 1.3100437 0.0670005 
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Table 7.  Gene Ontology biological process associations with Cfp1(-/-) up-regulated 
genes that rescued. 
Term for up-regulated genes Count % p-Value 
GO:0009987~cellular process 171 51.975684 8.27E-05 
GO:0008152~metabolic process 123 37.386018 0.0463928 
GO:0065007~biological regulation 120 36.474164 0.0641973 
GO:0044238~primary metabolic process 110 33.43465 0.0513555 
GO:0044237~cellular metabolic process 106 32.218845 0.0323534 
GO:0019222~regulation of metabolic process 60 18.237082 0.0183699 
GO:0080090~regulation of primary metabolic process 54 16.413374 0.0311794 
GO:0060255~regulation of macromolecule metabolic process 54 16.413374 0.0344414 
GO:0051179~localization 54 16.413374 0.0287142 
GO:0031323~regulation of cellular metabolic process 53 16.109422 0.0828597 
GO:0007275~multicellular organismal development 49 14.893617 0.0725284 
GO:0051234~establishment of localization 48 14.589666 0.03942 
GO:0010468~regulation of gene expression 48 14.589666 0.060479 
GO:0006810~transport 48 14.589666 0.0355756 
GO:0010556~regulation of macromolecule biosynthetic process 46 13.981763 0.089138 
GO:0048856~anatomical structure development 44 13.37386 0.0524091 
GO:0045449~regulation of transcription 44 13.37386 0.0735059 
GO:0048518~positive regulation of biological process 42 12.765957 2.05E-04 
GO:0044267~cellular protein metabolic process 42 12.765957 0.0648552 
GO:0016043~cellular component organization 42 12.765957 0.0161893 
GO:0048522~positive regulation of cellular process 37 11.246201 6.04E-04 
GO:0048513~organ development 37 11.246201 0.0245824 
GO:0048519~negative regulation of biological process 32 9.7264438 0.0139719 
GO:0051252~regulation of RNA metabolic process 31 9.4224924 0.082593 
GO:0043412~biopolymer modification 31 9.4224924 0.0220775 
GO:0006996~organelle organization 31 9.4224924 0.0013132 
GO:0006464~protein modification process 31 9.4224924 0.0122951 
GO:0006355~regulation of transcription, DNA-dependent 31 9.4224924 0.0706858 
GO:0006950~response to stress 29 8.8145897 0.0167599 
GO:0043687~post-translational protein modification 28 8.5106383 0.0071279 
GO:0048523~negative regulation of cellular process 27 8.2066869 0.049076 
GO:0009653~anatomical structure morphogenesis 26 7.9027356 0.0401944 
GO:0006508~proteolysis 24 7.2948328 0.0520837 
GO:0006796~phosphate metabolic process 23 6.9908815 0.0158859 
GO:0006629~lipid metabolic process 21 6.3829787 0.006044 
GO:0009605~response to external stimulus 20 6.0790274 0.0052709 
GO:0007399~nervous system development 20 6.0790274 0.0732855 
GO:0044255~cellular lipid metabolic process 19 5.775076 5.41E-04 
GO:0016310~phosphorylation 19 5.775076 0.03122 
GO:0010646~regulation of cell communication 19 5.775076 0.0556288 
GO:0000003~reproduction 19 5.775076 0.0087016 
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Table 7.  Gene Ontology biological process associations with Cfp1(-/-) up-regulated 
genes that rescued. (cont.) 
Term for up-regulated genes Count % p-Value 
GO:0044085~cellular component biogenesis 18 5.4711246 0.0163518 
GO:0031325~positive regulation of cellular metabolic process 18 5.4711246 0.0233502 
GO:0009966~regulation of signal transduction 18 5.4711246 0.0290292 
GO:0009893~positive regulation of metabolic process 18 5.4711246 0.0378409 
GO:0051276~chromosome organization 17 5.1671733 5.92E-04 
GO:0050793~regulation of developmental process 17 5.1671733 0.0159741 
GO:0010604~positive regulation of macromolecule metabolic process 17 5.1671733 0.0384304 
GO:0009888~tissue development 17 5.1671733 0.0408015 
GO:0042127~regulation of cell proliferation 16 4.8632219 0.0213624 
GO:0022607~cellular component assembly 16 4.8632219 0.0155275 
GO:0009887~organ morphogenesis 16 4.8632219 0.0445547 
GO:0006468~protein amino acid phosphorylation 16 4.8632219 0.0744086 
GO:0006357~regulation of transcription from RNA polymerase II promoter 16 4.8632219 0.0574909 
GO:0051173~positive regulation of nitrogen compound metabolic process 15 4.5592705 0.0356077 
GO:0031328~positive regulation of cellular biosynthetic process 15 4.5592705 0.0493491 
GO:0009891~positive regulation of biosynthetic process 15 4.5592705 0.0528695 
GO:0009611~response to wounding 15 4.5592705 0.0010832 
GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic 
acid metabolic process 14 4.2553191 0.0555018 
GO:0010557~positive regulation of macromolecule biosynthetic process 14 4.2553191 0.0705006 
GO:0048598~embryonic morphogenesis 13 3.9513678 0.0105262 
GO:0045941~positive regulation of transcription 13 3.9513678 0.0675957 
GO:0043436~oxoacid metabolic process 13 3.9513678 0.0708097 
GO:0042180~cellular ketone metabolic process 13 3.9513678 0.081852 
GO:0019752~carboxylic acid metabolic process 13 3.9513678 0.0708097 
GO:0010628~positive regulation of gene expression 13 3.9513678 0.0792678 
GO:0007420~brain development 13 3.9513678 0.0018568 
GO:0007417~central nervous system development 13 3.9513678 0.0128639 
GO:0006325~chromatin organization 13 3.9513678 0.0038513 
GO:0006082~organic acid metabolic process 13 3.9513678 0.0714219 
GO:0051246~regulation of protein metabolic process 12 3.6474164 0.0215394 
GO:0006952~defense response 12 3.6474164 0.0908784 
GO:0006066~alcohol metabolic process 12 3.6474164 0.0256331 
GO:0003006~reproductive developmental process 12 3.6474164 0.0028461 
GO:0051172~negative regulation of nitrogen compound metabolic process 11 3.343465 0.096226 
GO:0048646~anatomical structure formation involved in morphogenesis 11 3.343465 0.0592581 
GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic 
acid metabolic process 11 3.343465 0.0906665 
GO:0045595~regulation of cell differentiation 11 3.343465 0.0791025 
GO:0032787~monocarboxylic acid metabolic process 11 3.343465 0.0092512 
GO:0019953~sexual reproduction 11 3.343465 0.0791025 
GO:0016481~negative regulation of transcription 11 3.343465 0.0646483 
GO:0060429~epithelium development 10 3.0395137 0.0256687 
GO:0051253~negative regulation of RNA metabolic process 10 3.0395137 0.0535652 
GO:0051128~regulation of cellular component organization 10 3.0395137 0.0723915 
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Table 7.  Gene Ontology biological process associations with Cfp1(-/-) up-regulated 
genes that rescued. (cont.) 
Term for up-regulated genes Count % p-Value 
GO:0048610~reproductive cellular process 10 3.0395137 0.0015438 
GO:0045892~negative regulation of transcription, DNA-dependent 10 3.0395137 0.0513362 
GO:0008284~positive regulation of cell proliferation 10 3.0395137 0.0337586 
GO:0007167~enzyme linked receptor protein signaling pathway 10 3.0395137 0.0271792 
GO:0002682~regulation of immune system process 10 3.0395137 0.0646006 
GO:0060548~negative regulation of cell death 9 2.7355623 0.0377779 
GO:0043069~negative regulation of programmed cell death 9 2.7355623 0.0370824 
GO:0043066~negative regulation of apoptosis 9 2.7355623 0.0334225 
GO:0040008~regulation of growth 9 2.7355623 0.0470055 
GO:0019637~organophosphate metabolic process 9 2.7355623 0.0062845 
GO:0016568~chromatin modification 9 2.7355623 0.0313595 
GO:0006954~inflammatory response 9 2.7355623 0.0243772 
GO:0006644~phospholipid metabolic process 9 2.7355623 0.0039805 
GO:0002684~positive regulation of immune system process 9 2.7355623 0.015327 
GO:0046486~glycerolipid metabolic process 8 2.4316109 0.0040188 
GO:0022603~regulation of anatomical structure morphogenesis 8 2.4316109 0.027008 
GO:0000122~negative regulation of transcription from RNA polymerase II promoter 8 2.4316109 0.0693751 
GO:0048732~gland development 7 2.1276596 0.0873439 
GO:0048584~positive regulation of response to stimulus 7 2.1276596 0.0705596 
GO:0042060~wound healing 7 2.1276596 0.0080451 
GO:0010627~regulation of protein kinase cascade 7 2.1276596 0.0341475 
GO:0002009~morphogenesis of an epithelium 7 2.1276596 0.053319 
GO:0001655~urogenital system development 7 2.1276596 0.0265355 
GO:0051604~protein maturation 6 1.8237082 0.0169203 
GO:0051347~positive regulation of transferase activity 6 1.8237082 0.0595808 
GO:0050778~positive regulation of immune response 6 1.8237082 0.0611103 
GO:0045087~innate immune response 6 1.8237082 0.0257038 
GO:0043408~regulation of MAPKKK cascade 6 1.8237082 0.0149292 
GO:0042110~T cell activation 6 1.8237082 0.0347324 
GO:0016485~protein processing 6 1.8237082 0.0131015 
GO:0007281~germ cell development 6 1.8237082 0.0206169 
GO:0002526~acute inflammatory response 6 1.8237082 0.0085385 
GO:0002460~adaptive immune response based on somatic recombination of immune 
receptors built from immunoglobulin superfamily domains 6 1.8237082 0.0099126 
GO:0002250~adaptive immune response 6 1.8237082 0.0099126 
GO:0070647~protein modification by small protein conjugation or removal 5 1.5197568 0.0788601 
GO:0065004~protein-DNA complex assembly 5 1.5197568 0.0305619 
GO:0051605~protein maturation by peptide bond cleavage 5 1.5197568 0.018378 
GO:0050878~regulation of body fluid levels 5 1.5197568 0.0498981 
GO:0050817~coagulation 5 1.5197568 0.0234518 
GO:0045017~glycerolipid biosynthetic process 5 1.5197568 0.0125202 
GO:0042493~response to drug 5 1.5197568 0.0482186 
GO:0030879~mammary gland development 5 1.5197568 0.0449553 
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Table 7.  Gene Ontology biological process associations with Cfp1(-/-) up-regulated 
genes that rescued. (cont.) 
Term for up-regulated genes Count % p-Value 
GO:0030217~T cell differentiation 5 1.5197568 0.0305619 
GO:0008654~phospholipid biosynthetic process 5 1.5197568 0.0403008 
GO:0007599~hemostasis 5 1.5197568 0.0245586 
GO:0007596~blood coagulation 5 1.5197568 0.0234518 
GO:0006650~glycerophospholipid metabolic process 5 1.5197568 0.0482186 
GO:0006333~chromatin assembly or disassembly 5 1.5197568 0.0900312 
GO:0002449~lymphocyte mediated immunity 5 1.5197568 0.0305619 
GO:0002443~leukocyte mediated immunity 5 1.5197568 0.0498981 
GO:0002253~activation of immune response 5 1.5197568 0.0449553 
GO:0046777~protein amino acid autophosphorylation 4 1.2158055 0.0832287 
GO:0046164~alcohol catabolic process 4 1.2158055 0.0803244 
GO:0043410~positive regulation of MAPKKK cascade 4 1.2158055 0.0364083 
GO:0043406~positive regulation of MAP kinase activity 4 1.2158055 0.0638737 
GO:0042472~inner ear morphogenesis 4 1.2158055 0.0861778 
GO:0030850~prostate gland development 4 1.2158055 0.0224468 
GO:0016567~protein ubiquitination 4 1.2158055 0.0832287 
GO:0009880~embryonic pattern specification 4 1.2158055 0.016817 
GO:0008643~carbohydrate transport 4 1.2158055 0.066496 
GO:0007179~transforming growth factor beta receptor signaling pathway 4 1.2158055 0.0384039 
GO:0006959~humoral immune response 4 1.2158055 0.0515132 
GO:0060742~epithelial cell differentiation involved in prostate gland development 3 0.9118541 0.0167571 
GO:0060740~prostate gland epithelium morphogenesis 3 0.9118541 0.0612312 
GO:0060512~prostate gland morphogenesis 3 0.9118541 0.0654715 
GO:0046632~alpha-beta T cell differentiation 3 0.9118541 0.0345672 
GO:0046631~alpha-beta T cell activation 3 0.9118541 0.0491225 
GO:0021575~hindbrain morphogenesis 3 0.9118541 0.0612312 
GO:0017015~regulation of transforming growth factor beta receptor signaling 
pathway 3 0.9118541 0.0787472 
GO:0006958~complement activation, classical pathway 3 0.9118541 0.0787472 
GO:0006898~receptor-mediated endocytosis 3 0.9118541 0.0416027 
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Table 8.  PANTHER molecular function identified for Cfp1(-/-) up- and down-
regulated genes that rescued. 
Cfp1(-/-) mis-regulated genes that rescued, significant at  p<0.0001 and +/- 1.5 fold change 
were submitted for analysis as described in materials and methods. 
Terms for down-regulated genes 
Gene 
count % p-Value 
MF00042:Nucleic acid binding 47 14.29 0.059401186 
MF00036:Transcription factor 39 11.85 0.018856154 
MF00082:Transporter 16 4.86 0.043200469 
MF00038:Homeobox transcription factor 9 2.74 0.021659425 
MF00275:Transcription cofactor 6 1.82 0.083071924 
MF00102:Protease inhibitor 6 1.82 0.095065112 
MF00250:Serine protease inhibitor 5 1.52 0.081766783 
MF00013:Tyrosine protein kinase receptor 4 1.22 0.092260048 
MF00088:Apolipoprotein 3 0.91 0.051576208 
    
Terms for up-regulated genes    
MF00042:Nucleic acid binding 38 16.59 0.019296911 
MF00141:Hydrolase 14 6.11 0.027990075 
MF00123:Oxidoreductase 12 5.24 0.063821958 
MF00053:Other RNA-binding protein 8 3.49 0.005414587 
MF00166:Isomerase 7 3.06 0.003302667 
MF00118:Synthase and synthetase 7 3.06 0.023620804 
MF00126:Dehydrogenase 7 3.06 0.023620804 
MF00120:Synthetase 6 2.62 0.002706699 
MF00156:Other hydrolase 6 2.62 0.042330298 
MF00157:Lyase 5 2.18 0.075028703 
MF00139:Acyltransferase 4 1.75 0.0877264 
MF00138:Transaminase 3 1.31 0.024511184 
MF00288:Amino acid transporter 3 1.31 0.044197149 
MF00121:Aminoacyl-tRNA synthetase 3 1.31 0.054309725 
MF00167:Epimerase/racemase 3 1.31 0.088710546 
MF00098:Large G-protein 3 1.31 0.094945307 
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Table 9.  Kegg pathways identified in Cfp1(-/-) up- and down-regulated genes that 
rescued. 
Cfp1(-/-) mis-regulated genes that rescued, significant at  p<0.0001 and +/- 1.5 fold change 
were submitted for analysis as described in materials and methods. 
Down-regulated genes 
Gene 
count % p-Value 
mmu00970:Aminoacyl-tRNA biosynthesis 4 1.746724891 0.025263006 
mmu03040:Spliceosome 6 2.620087336 0.039386521 
mmu04350:TGF-beta signaling pathway 5 2.183406114 0.042410534 
mmu03010:Ribosome 5 2.183406114 0.045486254 
mmu00010:Glycolysis / Gluconeogenesis 4 1.746724891 0.083572779 
mmu05218:Melanoma 4 1.746724891 0.09234171 
Up-regulated genes    
mmu05010:Alzheimer's disease 8 2.431611 0.011402 
mmu00565:Ether lipid metabolism 4 1.215805 0.011572 
mmu00010:Glycolysis / Gluconeogenesis 5 1.519757 0.013339 
mmu04610:Complement and coagulation cascades 5 1.519757 0.018544 
mmu00561:Glycerolipid metabolism 4 1.215805 0.025535 
mmu00564:Glycerophospholipid metabolism 4 1.215805 0.062319 
mmu00350:Tyrosine metabolism 3 0.911854 0.09795 
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Table 10.  Identification of Cfp1(-/-) up-regulated genes not rescued. 
Gene lists were created using p<0.05 and + 1.5 fold change cutoff for consistent up-
regulation in N1 and N2 as described in materials and methods. 
Gene 
Symbol Gene Description Chr Gene Ontology Biological Process 
3110045C21
Rik 
RIKEN cDNA 3110045C21 gene chr1 --- 
4833420G17
Rik 
RIKEN cDNA 4833420G17 gene chr13 --- 
6430706D22
Rik /// Hjurp 
RIKEN cDNA 6430706D22 gene /// 
Holliday junction recognition protein 
chr1  cell cycle // chromosome segregation // centromeric core 
chromatin assembly  
6720457D02
Rik 
RIKEN cDNA 6720457D02 gene chr10 --- 
B230117O15
Rik 
RIKEN cDNA B230117O15 gene chr4 --- 
BC003267 cDNA sequence BC003267 chr8 regulation of transcription, DNA-dependent  
BC005512 /// 
F630007L15
Rik /// 
Gm6958 
cDNA sequence BC005512 /// RIKEN 
cDNA F630007L15 gene /// predicted 
gene 6958 
---  viral infectious cycle  
Cdv3 carnitine deficiency-associated gene 
expressed in ventricle 3 
chr9 --- 
Clta clathrin, light polypeptide (Lca) chr4  endocytosis // vesicle-mediated transport 
Csnk1d casein kinase 1, delta chr11  protein amino acid phosphorylation // Wnt receptor 
signaling pathway //  positive regulation of proteasomal 
ubiquitin-dependent protein catabolic process // circadian 
regulation of gene expression // 
Cyr61 cysteine rich protein 61 chr3  regulation of cell growth  // intussusceptive angiogenesis 
//  chemotaxis  // cell adhesion // labyrinthine layer blood 
vessel development  
Dnaja2 DnaJ (Hsp40) homolog, subfamily A, 
member 2 
chr8  protein folding // response to heat // 
Duxbl /// 
Gm10394 
double homeobox B-like /// predicted 
gene 10394 
chr14 regulation of transcription, DNA-dependent  
Dzip1 DAZ interacting protein 1 chr14  multicellular organismal development  // spermatogenesis 
// cell differentiation  
Phgdh  3-phosphoglycerate dehydrogenase chr14  glutamine metabolic process //multiple metabolic 
processes and neural development 
Gm5124 predicted pseudogene 5124 chrX --- 
Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme 
A reductase 
chr13  steroid biosynthetic process // cholesterol biosynthetic 
process // visual learning // embryonic development // 
coenzyme A metabolic process  // negative regulation of 
MAP kinase activity  
Hyal2 hyaluronoglucosaminidase 2 chr9  carbohydrate metabolic process //  hyaluronan catabolic 
process  
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Table 10.  Identification of Cfp1(-/-) up-regulated genes not rescued. (cont.) 
Gene 
Symbol Gene Description Chr Gene Ontology Biological Process 
Iqcc IQ motif containing C chr4 --- 
Khdrbs1 KH domain containing, RNA binding, 
signal transduction associated 1 
chr4  transcription // cell cycle // cell surface receptor linked 
signaling pathway // negative regulation of transcription // 
regulation of RNA export from nucleus  
Lamc2 laminin, gamma 2 chr1  cell adhesion  
Lnx1 ligand of numb-protein X 1 chr5 ubiquitin-dependent protein catabolic process // inferred 
from direct assay  
Mest mesoderm specific transcript chr6 regulation of lipid storage // response to retinoic acid //  
Mypn myopalladin chr10 --- 
Nrp2 neuropilin 2 chr1 neural crest cell migration // cell adhesion // multicellular organismal 
development // nervous system development // axon guidance // heart 
development // cell differentiation //  
Ostc oligosaccharyltransferase complex 
subunit 
chr3 --- 
Parp3 poly (ADP-ribose) polymerase family, 
member 3 
chr9  protein amino acid ADP-ribosylation  
Peg3 paternally expressed 3 chr7 apoptosis  
Pgap2 post-GPI attachment to proteins 2 chr7  GPI anchor biosynthetic process // anti-apoptosis // response to DNA 
damage stimulus  
Pigo phosphatidylinositol glycan anchor 
biosynthesis, class O 
chr4 GPI anchor biosynthetic process // metabolic process // inferred from 
electronic annotation 
Pla2g4a phospholipase A2, group IVA (cytosolic, 
calcium-dependent) 
chr1 ovulation from ovarian follicle // luteolysis // positive regulation of cell 
proliferation // response to heat // response to hormone stimulus / 
Plcxd2 phosphatidylinositol-specific 
phospholipase C, X domain containing 2 
chr16 lipid metabolic process  
Prdx2 peroxiredoxin 2 chr8 activation of MAPK activity // inferred from mutant phenotype // respiratory 
burst involved in inflammatory response // response to oxidative stress // 
negative regulation of T cell differentiation // thymus development // 
homeostasis of number of cells 
Ptprf protein tyrosine phosphatase, receptor 
type, F 
chr4 negative regulation of cytokine-mediated signaling pathway // nervous 
system development  // negative regulation of epidermal growth factor 
receptor signaling pathway  // positive regulation of apoptosis // multiple 
receptor pathways 
Ptprg protein tyrosine phosphatase, receptor 
type, G 
chr14 protein amino acid dephosphorylation // negative regulation of neuron 
projection development  
Rbp1 retinol binding protein 1, cellular chr9 regulation of granulocyte differentiation // inferred from mutant phenotype // 
response to vitamin A // retinol metabolic process 
Reep3 receptor accessory protein 3 chr10 --- 
Riok2 RIO kinase 2 (yeast) chr17 protein amino acid phosphorylation 
Sar1a SAR1 gene homolog A (S. cerevisiae) chr10 transport // intracellular protein transport // multicellular organismal 
development  
Slc1a5 solute carrier family 1 (neutral amino 
acid transporter), member 5 
chr7 transport //dicarboxylic acid transport // extracellular amino acid transport // 
L-serine transport  
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Table 11.  Identification of Cfp1(-/-) down-regulated genes not rescued. 
Gene lists were created using p<.05 and ≤-1.5 fold change cutoff for consistent down-
regulation in N1 and N2 as described in materials and methods. 
Gene 
Symbol Gene Description Chr Gene Ontology Biological Process 
Ramp3 
receptor (calcitonin) activity 
modifying protein 3 chr11 
intracellular protein transport //G-protein coupled receptor 
protein signaling pathway  
1700029I01Rik RIKEN cDNA 1700029I01 gene chr4 regulation of transcription, DNA-dependent  
6820431F20Rik cadherin 11 pseudogene chr8 --- 
C330019L16Rik 
/// Gm2381 
RIKEN cDNA C330019L16 gene 
/// predicted gene 2381 chr7 cellular response to heat  
Ccnb1ip1 cyclin B1 interacting protein 1 chr14 
blastocyst formation // apoptosis //meiotic metaphase I // 
spermatid development // organ growth //chiasma assembly 
Ciapin1 
cytokine induced apoptosis 
inhibitor 1 chr8 apoptosis // anti-apoptosis // hemopoiesis  
Dvl1 
dishevelled, dsh homolog 1 
(Drosophila) chr4 
regulation of neurotransmitter levels //negative regulation of 
protein kinase activity // multicellular organismal 
development // Wnt receptor signaling pathway // 
Frg1 FSHD region gene 1 chr8 rRNA processing// RNA splicing //ribosome biogenesis  
Gprc5b 
G protein-coupled receptor, 
family C, group 5, member B chr7 
signal transduction // G-protein coupled receptor protein 
signaling pathway  
Jam2 junction adhesion molecule 2 chr16 --- 
Nek3 
NIMA (never in mitosis gene a)-
related expressed kinase 3 chr8 protein amino acid phosphorylation //cell cycle // mitosis //  
Rbm45 RNA binding motif protein 45 chr2 
multicellular organismal development // nervous system 
development // cell differentiation 
Rwdd3 RWD domain containing 3 chr3 --- 
Sec23ip Sec23 interacting protein chr7 --- 
Ska1 
spindle and kinetochore 
associated complex subunit 1 chr18 
mitotic anaphase // chromosome segregation // regulation of 
microtubule polymerization or depolymerization  
Slc47a1 solute carrier family 47, member 1 chr11 transport // drug transmembrane transport  
Vegfc 
vascular endothelial growth factor 
C chr8 
angiogenesis //positive regulation of neuroblast proliferation 
// positive regulation of blood vessel endothelial cell 
migration // positive regulation of epithelial cell proliferation  
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CHAPTER 4:  DISCUSSION 
 
We have shown that Wdr82 is essential for development, Setd1A and Setd1B 
both play a critical role in cellular division, and Cfp1 plays a critical role in transcription 
regulation through both activation and repression of genes.  In addition, Cfp1 was 
identified as a critical regulator of genes for basic cellular processes including 
programmed cell death, development and multiple biosynthetic and metabolic pathways.   
  
4.1 Role of Wdr82 in Development 
We have demonstrated that Wdr82 is essential for embryonic development, 
although the earliest time point Wdr82 is required has yet to be determined.  We have not 
yet identified homozygous null Wdr82 embryos or ES cells (data not shown) and this 
suggests Wdr82 may be essential for mammalian cellular viability, consistent with Swd2 
requirement for yeast viability (Cheng et al., 2004).  Wdr82 depletion by siRNA has been 
used to evaluate the role of Wdr82 in several differentiated cell lines in previous studies, 
yet some protein is still detectable by western blot (Wu et al., 2008).  However, 
unicellular gametes containing a single copy of the disrupted Wdr82 allele are viable.  No 
phenotypic differences have been observed in heterozygous mice other than the 
interesting over-representation of Wdr82 heterozygous offspring following Wdr82 het 
cross-breeding and this merits further investigation. 
There is currently not enough information available to justify a solid hypothesis 
for the mechanism at work, but the distribution frequency of heterozygous embryos to 
WT suggests altered functionality in either egg or sperm as the skewed frequency 
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compared to an expected Mendelian frequency would be less dramatic if both were 
equally affected.  Further investigation is needed to identify the frequency and functional 
impact of the disrupted Wdr82 gene in oocytes and spermatazoa followed by an 
evaluation of events following fertilization.  Temporal differences exist in male and 
female gamete meiosis and X-inactivation pre- and post-fertilization that may play a role 
in this unusual distribution favoring heterozygotes. 
We have demonstrated functional β-galactosidase by theWdr82 fusion transcript 
through X-gal staining, yet it is unknown if the truncated Wdr82 fragment has any 
functionality.  Previous studies with Swd2 truncations suggest it is unlikely as no viable 
yeast could be identified with any truncation of the Swd2 protein (Cheng et al., 2004;  
Roguev et al., 2004;  Dichtl et al., 2004).  However, partial Wdr82 may still be able to 
interact with one or more of the multiple proteins it has been found to associate with.  
This could be determined through immuno-precipitation of the β-galactosidase fusion 
protein, followed by isolation on page gel and identification of binding partners with 
mass spectrometry.  The functional β-galactosidase will enable further studies to identify 
the developmental stages where Wdr82 is expressed, including identification of gamete 
distribution and adult tissue assessment by staining with X-gal and/or antibody. 
Wdr82 het ES cells exhibit reduced amounts of Wdr82 protein compared to WT, 
indicating WT levels are not required for survival and heterozygous mice appear normal.  
The difference observed in differentiation dynamics suggests that altered Wdr82 levels 
does have a functional impact and may play a role in cellular division and differentiation, 
yet this observation may be due to clonal variation.  The impact of Wdr82 protein levels 
can be verified by increasing Wdr82 levels in the Wdr82 het cell line with transfection of 
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Wdr82 cDNA, and/or reduced Wdr82 levels in WT ES cells by siRNA and observation 
of differential dynamics under these altered conditions.   
 
4.2 Role of Setd1B and Setd1A in cellular division 
Over-expression of either full length Setd1 or truncated Setd1B resulted in fewer 
viable cells after 4 days growth than vector, demonstrating a significant role for both 
Setd1 proteins in cellular division.  With and without the ability to bind Wdr82, Setd1B 
and B-676 over-expression had fewer viable cells than Setd1A, suggesting a functional 
difference between the two methyltransferases independent of interaction with Wdr82.  
Setd1B truncations B-2482 through B-4981 were not statistically different than Setd1A, 
suggesting a unique binding motif is located between nucleotides 676 and 2482 of 
Setd1B cDNA.  This finding suggests structural differences in the central region of the 
two methyltransferases play an important role in functionality, consistent with the HCF-1 
binding site found in the central region of Setd1A, but not Setd1B.  HCF-1 is a 
transcriptional co-activator that interacts with Mll1 in addition to Setd1A, and is required 
for targeting these methyltransferases to IE62 target genes important for herpes simplex 
virus activation (Narayanan et al., 2007).  HCF-1 plays a significant role in the G1 to S 
transition.  For example, G1 to S transition is enabled with removal of a repressive 
H4K20 mono-methylation mark by PHF8.  PHF8 is recruited to E2F1 regulated 
promoters based on interaction with di- and trimethylated H3K4 in conjunction with 
E2F1, HCF-1 and Setd1A (Liu et al., 2010).  However, both Setd1A and Setd1B over-
expression resulted in a higher percentage of cells in G1 phase and fewer in S phase 
compared to vector, yet not significantly different from each other as observed with PI 
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cell cycle analysis.  This confirms both Setd1 proteins play a role in the cell cycle, but the 
mechanism for differences observed in cell numbers cannot be identified.  It is likely that 
apoptosis plays a role, and can be evaluated with several different methods including 
evaluation of the fragmentation of DNA in which late stage apoptotic cells break into 
different length pieces (TUNEL assay).  Alternatively, assays for alteration in membrane 
asymmetry with phosphatidylserine translocation from cytoplasmic to extracellular side 
of the cell membrane, or activation of apoptotic caspases for early apoptotic events can 
be pursued. 
Previously, our lab showed that over-expression of the carboxyl-terminal 
fragment of either Setd1A or Setd1B resulted in lower levels of both Setd1 proteins (Lee 
et al., 2007).  It is unknown what impact over-expression of full length or partial Setd1B 
fragments has on endogenous levels of either Setd1A or Setd1B.  It is possible that over-
expression of Setd1B truncations actually reduce Setd1A and/or Setd1B levels similar to 
the observation with the small carboxyl-terminal fragments, and this needs to be carefully 
characterized.  Nonetheless, over-expression of either full length Setd1 protein resulted in 
decreased number of viable cells compared to vector, which suggests increased levels of 
Setd1 alters cell division dynamics.  Since an increase in apoptosis and slow growth was 
observed with reduced Setd1A levels (Tate et al., 2009b), it is possible that the level of 
Setd1 proteins play a role in cell cycle regulation.  Alternatively, the relative levels of 
Setd1A to Setd1B may impact cell cycle progression.   
Although growth characteristics were not evaluated, reduction of Setd1B by 
siRNA did not reduce levels of Setd1A in NIH 3T3 cells (Wu et al., 2008). 
Unfortunately, levels of Setd1B could not be evaluated due to lack of antibody.  It is 
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interesting to note that lowered Setd1A levels accompany reduced H3K4 trimethylation 
in siRNA Wdr82 depleted cells which is not replicated by siRNA reduction of Setd1A or 
Setd1B alone.  The reduced level of H3K4 trimethylation is replicated when both Setd1 
proteins are reduced together.  Increased levels of H3K4 trimethylation are observed in 
Cfp1 null ES cells despite lowered Setd1A levels, suggesting Setd1B may be responsible. 
(Wu et al., 2008; Tate et al., 2010).  A better understanding of the relationship between 
Setd1A and Setd1B levels might help further identify the functional role of these 
methyltransferases.  
 
4.3 Cfp1 is a critical regulator of transcription 
 We have previously shown that ES cells lacking Cfp1 have increased levels of 
global H3K4 trimethylation with mislocalization to areas of heterochromatin by confocal 
analysis.  Although H3K4 trimethylation is primarily associated with active transcription, 
microarray analysis demonstrated that altered H3K4 trimethylation results in increased 
and decreased transcription of genes, indicating a role in transcriptional repression as 
well.  This is consistent with the finding that H3K4 trimethylation is required for 
silencing of telomeres, rDNA , HML and  HMR loci in Saccharomyces cerevisiae 
(Fingerman et al., 2005).  Consistently, a larger number of genes were up-regulated in 
Cfp1 null ES cells than down-regulated, suggesting the repressive role of Cfp1 is not 
minimal.  
The large numbers of genes differentially expressed between ES cells with and 
without Cfp1 clearly implicate Cfp1 as a critical regulator of gene expression.  The large 
difference between the two nulls is suggestive of primary and secondary effects from the 
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absence of Cfp1.  Consistent mis-regulation and rescue most likely reveal Cfp1 targeted 
genes, and identification of these genes can be utilized for future study.  However, the 
lack of complete recovery in Rescue cell line may suggest absence of Cfp1 results in a 
sustainably altered epigenetic program at some loci.  Altered epigenetic programming 
preventing Cfp1 interaction may contribute to differences observed between the two Cfp1 
nulls or alternatively, may be the random signaling due to lack of tight regulation of 
cellular processes in absence of Cfp1.  Exploration of specific loci that did not rescue 
upon re-introduction of Cfp1 should be performed to assess epigenetic marks including 
DNA methylation status. 
Cfp1 interacts with Setd1A, Setd1B, Mll1 and Mll2 and changes observed in 
transcription are likely due to altered functionality of these methyltransferases in addition 
to changes in DNA methylation (Dehé et al., 2006;  Ansari et al., 2008;  Wu et al., 2008,  
Lee et al., 2007).  Evidence suggests the majority of global H3K4 trimethylation is 
attributed to Setd1A as opposed to Mll methyltransferases, however, the role of Setd1B 
has not been sufficiently evaluated (Wu et al., 2008; Wang et al., 2009).  Setd1A levels 
decrease in the absence of Cfp1 and the methyltransferases(s) responsible for increased 
H3K4 trimethylation is unknown.  The list of aberrant genes rescued with re-introduction 
of Cfp1 should provide a targeted focus for investigation of methyltransferase occupancy 
by chromatin immunoprecipitation at specific loci, eliminating the need for genome wide 
investigation.  Identification of specific methyltransferases at targeted genes should help 
explain the role of multiple H3K4 specific methyltransferases interacting with Cfp1. 
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4.4 Cfp1 regulated transcription impacts multiple basic cellular processes 
 Genes in every chromosome examined, including the X chromosome exhibited 
altered levels of transcription in absence of Cfp1 and were associated with a broad range 
of biological processes.  DAVID functional analysis associated up and down regulated 
genes with primary processes, including key developmental genes and those involved in 
apoptosis, consistent with phenoytpe defects observed in absence of Cfp1.  Specifically, 
genes that require tight regulation during development such as Fgf4 and Suz12, were up-
regulated in addition to fifteen homeobox containing genes, confirming Cfp1 plays a 
critical role in regulating differentiation and development.  Notably, Xist which is 
important for X-inactivation was down-regulated and rescued suggesting H3K4 
methylation plays a role in maintaining X-inactivation critical for development.  Over 20 
genes involved in programmed cell death were identified, including decreased BID and 
Bnip3L and increased Cidea (cell death inducing DNA fragmentation factor), consistent 
with the previous finding of increased apoptosis in Cfp1 depleted cells (Carlone & 
Skalnik, 2001;  Tate et al., 2009b).  Several genes implicated in DNA repair were mis-
regulated, including the down regulation of XPA, consistent with the finding of increased 
susceptibility to DNA damage in Cfp1 null ES cells (Tate et al., 2009a).  Not 
surprisingly, the largest group of mis-regulated genes was associated with nucleic acid 
interacting proteins indicating a critical link between Cfp1 and DNA and RNA 
machinery.  Notably, many of the up-regulated genes facilitate post-translational 
modifications necessary for signaling events in molecular pathways and development and 
it is difficult to discern if these are a primary or secondary effect from loss of Cfp1.  A 
correlation between mis-regulated genes and CGI promoters could strengthen the case for 
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direct correlation with Cfp1, as Cfp1 was found highly enriched at CGI sites (Thomson et 
al., 2010).   
In conclusion, these studies show a critical link between Cfp1 and H3K4 
trimethylation to regulation of basic cellular processes.  The interaction of Cfp1 and 
Wdr82 with both common and distinct methyltransferases calls for a closer look at those 
targeted to specific genes, along with clarification of their roles in activation or 
suppression of transcription. 
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